{"body":"<p><strong>A5.10 Mefloquine<\/strong><\/p>&#13;\n&#13;\n<p><em><strong>Therapeutic indications <\/strong><\/em><\/p>&#13;\n&#13;\n<p>Mefloquine is indicated for the chemoprophylaxis of malaria caused by all species. In combination with artesunate, it is also recommended for treatment of uncomplicated malaria.<\/p>&#13;\n&#13;\n<p><strong>Structure and mechanism of action<\/strong><\/p>&#13;\n&#13;\n<p>Mefloquine, a 4-methanolquinoline, is structurally related to quinine and belongs to the aryl amino- alcohol group of drugs (1). Mefloquine has two racemic forms, <em>erythro<\/em>- and <em>threo<\/em>-, each composed of a pair of enantiomers, of which the racemic mixture of the erythro- enantiomers is the most active against malaria parasites (1). Its mechanism of action is not fully understood but is thought to involve inhibition of parasite-mediated haem detoxification, a common mechanism of action of quinoline antimalarials. A more recent proposal is that it inhibits endocytosis of the cytosol by the parasite (2). Mefloquine has approximately the same stage specificity of action as quinine, killing primarily the large ring and trophozoite asexual parasites. It has no significant pre-erythrocytic activity.<\/p>&#13;\n&#13;\n<p><img alt=\"\" src=\"data:image\/gif;base64,R0lGODlhAAQXBbMAAAEBAf\/\/\/4WFg8XFxQeSldrZ2LfS5VRUVOHLpikoKPryz83n9aalpXTA3f786e7v8CH\/C1hNUCBEYXRhWE1QPD94cGFja2V0IGJlZ2luPSLvu78iIGlkPSJXNU0wTXBDZWhpSHpyZVN6TlRjemtjOWQiPz4gPHg6eG1wbWV0YSB4bWxuczp4PSJhZG9iZTpuczptZXRhLyIgeDp4bXB0az0iQWRvYmUgWE1QIENvcmUgNS42LWMxNDUgNzkuMTYzNDk5LCAyMDE4LzA4LzEzLTE2OjQwOjIyICAgICAgICAiPiA8cmRmOlJERiB4bWxuczpyZGY9Imh0dHA6Ly93d3cudzMub3JnLzE5OTkvMDIvMjItcmRmLXN5bnRheC1ucyMiPiA8cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0iIiB4bWxuczp4bXA9Imh0dHA6Ly9ucy5hZG9iZS5jb20veGFwLzEuMC8iIHhtbG5zOnhtcE1NPSJodHRwOi8vbnMuYWRvYmUuY29tL3hhcC8xLjAvbW0vIiB4bWxuczpzdFJlZj0iaHR0cDovL25zLmFkb2JlLmNvbS94YXAvMS4wL3NUeXBlL1Jlc291cmNlUmVmIyIgeG1wOkNyZWF0b3JUb29sPSJBZG9iZSBQaG90b3Nob3AgQ0MgMjAxOSAoV2luZG93cykiIHhtcE1NOkluc3RhbmNlSUQ9InhtcC5paWQ6QTdGQkY2NzJDNDFDMTFFOTk5MERGRjQ0MjFFOEJBQUUiIHhtcE1NOkRvY3VtZW50SUQ9InhtcC5kaWQ6QTdGQkY2NzNDNDFDMTFFOTk5MERGRjQ0MjFFOEJBQUUiPiA8eG1wTU06RGVyaXZlZEZyb20gc3RSZWY6aW5zdGFuY2VJRD0ieG1wLmlpZDpBN0ZCRjY3MEM0MUMxMUU5OTkwREZGNDQyMUU4QkFBRSIgc3RSZWY6ZG9jdW1lbnRJRD0ieG1wLmRpZDpBN0ZCRjY3MUM0MUMxMUU5OTkwREZGNDQyMUU4QkFBRSIvPiA8L3JkZjpEZXNjcmlwdGlvbj4gPC9yZGY6UkRGPiA8L3g6eG1wbWV0YT4gPD94cGFja2V0IGVuZD0iciI\/PgH\/\/v38+\/r5+Pf29fTz8vHw7+7t7Ovq6ejn5uXk4+Lh4N\/e3dzb2tnY19bV1NPS0dDPzs3My8rJyMfGxcTDwsHAv769vLu6ubi3trW0s7KxsK+urayrqqmop6alpKOioaCfnp2cm5qZmJeWlZSTkpGQj46NjIuKiYiHhoWEg4KBgH9+fXx7enl4d3Z1dHNycXBvbm1sa2ppaGdmZWRjYmFgX15dXFtaWVhXVlVUU1JRUE9OTUxLSklIR0ZFRENCQUA\/Pj08Ozo5ODc2NTQzMjEwLy4tLCsqKSgnJiUkIyIhIB8eHRwbGhkYFxYVFBMSERAPDg0MCwoJCAcGBQQDAgEAACH5BAAAAAAALAAAAAAABBcFAAT\/MMhJq7046827\/2AojmRpnmiqrmzrvnAsz3Rt33iu73zv\/8CgcEgsGo\/IpHLJbDqf0Kh0Sq1ar9isdsvter\/gsHhMLpvP6LR6zW673\/C4fE6v2+\/4vH7P7\/v\/gIGCg4SFhoeIiYqLjI2Oj5CRkpOUlZaXmJmam5ydnp+goaKjpKWmp6ipqqusra6vsLGys7S1tre4ubq7vL2+v8DBwsPExcbHyMnKy8zNzs\/Q0dLT1NXW19jZ2tvc3d7f4OHi4+Tl5ufo6err7O3u7\/Dx8vP09fb3+Pn6+\/z9\/v8AAwocSLCgwYMIEypcyLChw4cQI0qcSLGixYsYbzzYyLGjx48g\/ztmHEkymoMHA1KqXMmypcsBBh6UnEkTmYMCL3PqTGlgQc2fQH\/d3Em0Zc+gSJPaGlq0KUyfSqNKZcXUKdGYU7NqJVVVZYGvYMOKHft1gcytaNNq6vo0pNuPauPKncQW69y7eEHVPZu3r19Le\/8KHvwoMOHDiAsZTsy48Z7FjiNLjgN5suXLZypj3sy5i+bOoENP+Sy6tOkkpE+rXv0jNevXsGu4jk279orZtnPrDoF7t+\/fF3oDH\/5bOPHjtuuaffsWufPSbAeQnU6W7\/Prl6NbbVnAOvbvjbVvX1kAvHnH4sen7H6+\/eH06tm7n+83OvX7YL3T3x9XOXPm\/AUol\/9xAhaIF4EGJqgWggo2mBWDDkaYFIQSVlgThRZmOBKGGnZYEYcehggRiCKWuBCJJqZoEIoqthgQiy7GyA+MMtZ4D4025igPjjr22A6PPgaJDpBCFjkOkUYm6Q2SSjaZzWcPkOXklOd8hlNL+lGpJTeaXelSlluGaU2XOZUn5pnYkPmSmWi2SQ1IF3jJnZt0giMnS2zWqWc2d5K355\/Y9OkVoIRSI+h6hSYKzaHSKeooM4zm+eikxERK6aWVlonppsBYyumnu3gK6qi2iErqqbGYiuqqrKjK6qunuArrrKLISuutndiK666Y6Mrrr5P4CuywjghL7LGJGIvssoQoy+z\/s384C+20ekhL7bV1WIvttnBoy+23a3gL7rhmiEvuuWGYi+66XKjL7rtXuAvvvFLIS++9TdiL775I6Mvvv0P4C\/DAPghM8ME5GIzwwjQozPDDLzgM8cQqSEzxxSVYjPHGIGjM8ccbeAzyyBaITPLJAZiM8sgqr\/xxyy5vDHPMF89M88Q23\/xwzjovzHPPB\/8M9MBCD\/1v0Ubvi3TS9y7N9LxOP\/1u1FKvS3XV516N9bhab\/1t115vC3bY145N9rRmn\/1s2movy3bbx74N97AMMDAdmHOf\/AADAtTtt98D5K3z3gckYPjhhgsg+M0ODHAAAJBHDrnii8fc+OOSR055\/+UrX5655py77PnnAGweOsmjf2766SCnnvnqrHPsuuSwx47x7KDb3rrjpJeu++6Yq\/77x7hPPrzsvJNe+\/EMF+878xc7vzz0B0tPPcXWXw9x9to3n7zw3Xsf\/Ovhi9\/79OXjy336A6\/P\/r\/uv79v\/PLfS3\/9896Pf1b\/9Q8XV98jnyhO4r8C4m1\/c4DPeL5ywLUEkHajiJJ61nQUBOpBgeOxywAfmLtQKIBRE4SKBfGAwe1oMBT608QHJ5gTEY7QDiW0ygn1wkHjiWKFLHSJC19Ihxg6RT4bHB8EbwjCDO6Qh3KwD37wYxYACrGDoMAheZZ4nyMiEQ7+MeD\/RpHCTP9IcT1ahNMVe3gnIOaii5j4YgXHqAi2mBEXaLyEGq3IRkK4sYGxiKMl5ljHNpYRj7DQYyX42EdE3JEXgqQEIQtpiEPuIpGTWCQj7fhHRNbweR6U0xonOQhH6gKSkpAkJwPhyTNeEn1e1CQdR8mHUsLxlKMQJSv94MpbgDISspxlKyv5SFgScSWb1GUfarkUX2YSmKsU5h2IWYtbQiKXyiQhLz9pzCiqMpq0nKYuqvkJaGKzDszUSBjHSU7\/DeBv6EynOtfJznb+TQAJ6N0B3EnPetqTb3Yrpz73uUURePObCaykAwZK0IIalKAsKGIOF9qUAgigdxCNqEQnStGKWvT\/or1LgN0YylEWAhIDXxxAEw9KUoN+FKBYUCIVq3MCCXb0peNhQOEwStOa2vSmNE1A32DK04aetAIhXel0mohSMfiwKMnsAEp6ytSdfOWhOI2qVKdKUwEstalY\/dIIQprDGRbVMwq1SlI5cNWsmnU9A4AnVdfK1raWLqxn7aikOsBVFnr1q1s4KlHGuoGyxjWrUXqiWwdL2IkKAK5\/Zag\/EXuVn+IVCnrdCV814NfEMhUngi2sZjc7OcZaNj6LfeldH5vSPgmVpSao7GdhKtN4cva1r7Xqapv6Rrqa9rRicSxpm5BFcrZ0tj39SmZhS1y2Hha4PdVtAIKqz916IZw1\/1AtcnM43OJaV6rz9Ox0c6LcOSrXuV+Abg20u13uOBRx6E2vetfL3vYiDqLuja985xtPjZK3vOTp7jXBSxlt8oCfAObnfZnKN9dmbp74VYlMAszgcZLgn\/zNjH9zwQADS+4Ac+UEhCNcBvHK4gFq\/dwBBvDdRmyYw2PwcCxAbOHIjbjEjDgxisOgYliwmHQvPqZKgjljNNT4FTcWMYl1zJPJ9vi5E75FkA88ZGsi88hr+LErlnzhJndzv1D2cZJtQWUXW9kTMs5yXrdciy5DLsdO3rGRxZwFKbfCzABA85WfHCACNhjGJXEzK+AsZzBjeT8u7SiP0aLnVfD5y50Is\/9z6prDNQel0Ko4NJ4VoWjkMJqFjgYKpFMhaSI\/RUCXDuFdNo2KTqe5yKAesEsGvRVSn8LUc1ZzqvGE27FMekNkpgWs\/Uxn\/jC3uaPO9Sx2neg\/06fSg3G1KYitYWPPB9mCYdImmL0JBbQk08SB9l+krQlqq9DZ7tF2faKUn1uXwtuZOElYNjJrWd8M3UAT98Lg3TN5I4zeOrP3wfB9M30TjN808\/fAAB4zgQOM4C4z+L8QvjKF84vhKHP4viB+Monji+Iks\/i9MD4yjdOL4yD7tW\/3HWImm\/tiXK31ukne4jMjmmmhNiG2wQXyj8VchieHVs05dnOnjHbjJa9yzif\/1vOm\/PzjQffy0CGWcpUzkOU4fnnSRO5gqAt56Q\/z+Lx2vjGtw4vrGPP6u8COcnDrLekuxzrDxM4uslOM7etyO9HNTjK5M53uI7N71vEOMr2vne8f8\/vCDE7Ai6M9zlI3msA3wkC100rwCPN3oJ\/+9cP3+Wn6DrRXHP8qyB\/M3prP79gtn\/ihgf5QtR2X5wkGep1kmOak5\/znAd\/XSMn+VKsfmL3hk3pu5R5gmQfh7Uf1+39J3vXD\/1Tx+SV5EL4eW8vfl7VZMnMLhF705Ir+xWnvAecnH1Pat58YU3D9lXy\/E+R2enXOz43wG026YBRGZHdydH24f2jl94oDgjF\/\/53UPx\/3h3+2x3+qtmrV9w4BCDT5hyjA0H85wWr8kIAKiHwNWIBGwX7bIIE9s4CNIhS3pX5EJRAauIED6Au9NXIDMYIbSIG9wG34oIKD43wmeCf\/BxEwGINlgoF0QYM6GA83yDjeh0g8WBI\/+G7CJ4QsUYMPUYTvxoJnNIQkwYQ0s4C9NwsueA9SOIUlCEdQOBJZGDMc+Hx51IUZ8YVg6IRLQYYYYYYuE4ZPmIQ9CA9s2IZb2ExqeBFz6DJBmIZwSISxV0ccGId+1IdR+IeAWIeycIX2kIcxs4dWeIcWwYh0mIN2SIheaIh95IhjmITLgYIpiImHSImP6BIgaBCSOP+JoriJLyWGEQiKobgmgqgYFrgSByiHrgiIaOgKDkiKpniLbOSGqthRtYiAvviLiEgVH6hysXgNp3gzmoiMnFhOB9GMWqgTy\/gG7OYBilgP1DiFuWgJHFFuHLCN9NCNYOh8+4cJ5IYn6ZgB5DgP5niOqUgJ68gdDfSO8hCPjeh64PiMFYCPPliMhUSF1ygG9WiNGgCQtthyiFeQcBOGDtkFjNcUB6SQxMiQlzdKBOkIB0kUVRgAFukO+uiN83gIE\/lD9wiJFTGS8qgpicCBazKOKkkRLNmSsGgIHVkU3YFHIdkONbmPCEkIMGleH9WT7PCTqHiTgZCTTtUd7SiTllj\/hgKpkU4VkUqgbp7llLwxkxOBlG2oEwxQenTAlFWpXEa5Dl65MgtYNx8JByf5Q22ZkFwpEWmplocCOHkwlPZ4AmepDnW5MgUQli4hAAeASmxAlsg3aX2ZDn+JMnf5OAdglT\/wlg0Vl9o4lxHRmHrjJWCRVvVlN3Kgl1OUc4uJDpqpN2nlN4RpYCOGjYi5JlrJAqV5Dqd5MjJ1ALjZcoZpkF+xHZY5ArNpDrVJMoFZX1EnmTRAmTr5m8CJmTY4lcJUAMOVAK2JBqKJfTGgbAQxnHVXYfDFAGfwmqS4k7LRT1KJkWKpTHCWdmOgnB6ZjZ3BnSczAAwJOTqFnCqgbr4J\/5+gIZ\/EeXgu9wWMx1iUVxr+SZzTeVgS2ZtWwZyScaAk450ZBZ5aIJ6kyJ+mAaEj45kQhWFY4J5NiZ9+iJ4iejqXFGcMUKJkxaCVqaKFSKL8BWLwVZ1QEI5ZiaGsoaEj4wAy9Z31Eh8P8JSxoaN5J6HH2QQWOp4uWhNEyjLT6aFLIEGCiZK\/0aR9Z6SfkwCBowT4NKU6iaO2YaV9B1Wko1NbWgRR0lo7tZxLihRiCjJYmjn3iaatBQBm6pEOmqPQ+VXn1aGsqBGBSZiRc6eJ6RxvCjLS+Z1\/Ol5oJwBOhR2HCjIAaqcU2gOBOVMiFpYsGn+Quqd4xaHn04M4ManUWf83WAIekQoy9Nmh6fkCjoOpEUWdAuCo5ImqnopXMppRNJqc51RdWdo3eaobqRp4PTqhNkA4GKVTwbobwxp4k5qRK5Cmq2lROgWa9NGsH3OicbaoJACqFVWqbYoX2MoxxcmqLtA40\/qthdmqnQqjYparZaqgKpCmsDpRicOu3zGuHxOnkqNT8+o49ZlRwBqufqGv5Pqs3IoBQ5GuFCWr+GoeBkuu02mtI3CpyXpYBDsYEcsxz3qmHVOnFlWYFOsgG7sx3go+H4ASk1qm85SxiFGyG8OvLpaiHpBW9SpRsrqs7QGzGJOo5kpZvRqwWVqtLssYPHsxyGqsGUA4QvurJFb\/tEZ7qxdRePHZsUK6sL4qp+sqpBpytI9YFqBxonNKARZ7UcqqIl6bR9ZmqsNIAV3RE1BrJzIboBJwqU17YMDaImkbSAjAN7PaAG0rAQqAALM6qwwAgSXhs\/FKYidrry0bI3v7Cg7Qt4V7uIE7uIXbN4AbFXNrp4V5s7GaXXF7GZGri4FauQagApibuZurFH0KX9S6rqOLGaXbCjfht5XbtqtbuK2rFNpKrY46u5uxN+jJtTNxu5nbN4jrAbv7t4HbEOupriNrI69rckiBvMl7uCjQvALQuxPyuzM6vTaStJkqvNuAvckLuDDGvd6rFJ3bocHrIyr7pDSraaebvN17\/4Ds+7wMESUrK6fgGiR2i7Nn+xPom71KeAH7GxVMC7z51CPSereDimDmWw0HjMDftcBIMaqgq6vx6yONq64ei2u4i799M3MaDBTVW1FQCsIMm1Mim7AMccB1k7mWu1WEy7r8WxAO1cES1cI2MhRZC7wyrBDoK5gY7E85zLs7\/CIqK8HxWsQW0sBsVapSvCL3e7jnlL0hyLxL7Lwz8cRQrLQxMqpjnFPAarwOccQ9Qbk6HAIpvIYDLFVWVcbFqq4+DF\/yOhEHDLjce7g\/FccWMcffGlGPayIoAbLfulN8k8dZSsES0ccLMLklrLwnJcgTEahnrFMvzGSIHMKhW78SAP\/K4VvBxyDJy+XGufsBmGyDK0xRhSkTYlupHTK\/Y1yqiEavt1ytVzwj99u9qUvJCDxZrewQNnvL68omDGDIDwtoZfutZnpAhNywH3wiv9wAqZvK+AvIdPXF+UuXT2y2l6etQBwhVLzI0nGP82u2BWzE15zNDqAAlXzCeFTMCbE38ITM6Wx9dyxkEiJB\/6u14hsyBXbLA5sQfZzNIKnKTMwB9myKxxy7jkpZZOq0EdLDGCW6JHDO1DzCBJHQFDC481x\/D72d\/UzNcdm5\/pogiezIWts3eNbSyFzNAwHSExDP3mzJGlDSAaHJ4jzQcYKwBoISLq21zcwBpKyrD1zT7\/z\/jwwNxhnA0\/4QzrEL1BmguL\/ay8AR0dKrs0vr09CcXUxdwthsASKNvxAo1fzA1Q2LYHkavRoFaL0qzjTtAtNsr8FrynZI1gp909yr0wrsze0bEBEszkdNAUldx+7B0Xj9tMn5zA1rpgBh0049zwxAR2pdARyBgIrc0V4tAZ17yPkaqEM8qHmLA\/hc1BO81KaZfoBE2ZWNv4OtzW+csmWElmztuHt8AtIZsOX8HEktT6KsA1SNznrNCVJqqjzZ1CD11ALgVZmdMpVs1eBAvous1RdA1D56HbYs0YfdAjIt0dStDWk63awI2\/\/419wc0oJtZCq7zfs8Dj0806y9AhUt\/2RqvBt3HavRTATndcYabSdbbMJiid6xnb59TdsNrVS\/nL2O\/Q3F3dbD3QLaqtjEAbA\/\/dkwYMY\/fdyRkMjzXLliaOBA5dybpNaJbMKVG5Ye\/gjd3dWcV67y5NG50dJ0\/d0a0dl4bTf5DQ3lreIiLpd8vQE4vc0ahOIDDuQ7peHCoMvefaz33a+7XeM6jrMY6wSQba\/tXA2BGeLbPOLMnZDOfdkTgOReDt8tjgiMbeU4TgIqTcu04eQOjN078OJtXdfNIKVKnrwFHuY77dytm9kNruSmyuS6QNrIPN4RI9S2EdyPrOhK4OgC3ePGIK17bsPn7efu+NfPLRPRneSXbv+4hs5lr4zXdG4CYjvlq5HbOCu7VyDnkX3aygDioV656UniwaHePhHdel7rS57mfDDf3n3qqdWxr0Gv7IznViDsRAzsd9Drtc6WHYDrwfHUDAC4k5u+mZbivv7rxwDQmyzaPYCuEWXhp1HlsXrQEinp\/SruwoATZ67i9S3krJvgG3DWNmwAwrzgIbARoB7qLF4MYlzVo54CoT3hncHBGe7sa57ukE4LQ1HD0a6pJ0XtuZ7TbUzW1QftAJ\/Ozu4Gdq7bNP4Dve2npZHlpk7pW9DwekzspnDBl66pImDxwdHgWqzxKDDoey7zvrDf6V7wLGDdcgrnpBu0FxXDaRDyra7\/7MMG791O8c055HDM0Nc+AF882yKwVPEO30DvCfgc7g\/\/X1E+wSPvGBHuuAiPBuy+2mBqY\/8e8wOg8u6o6dP+xxIP1eT39jvf9d1W6j+s6keQ6h+fj6weynwfBYUd1mF\/bue09dlboFFf78DJ6bU9r07v62w5+GBQ+DNKq3IPBH7PnpER3tDM9Gzg83rc5tN2+dHegXxJ99ro3JUfrY3\/9PH9ZhzuwBmL1XI60WaP7qnf9m+A8qEL+LGi94Q+6jT\/52eO9Xxp6Ziv+pfA8rr64JD15kaL6AS\/B9q\/yPMeQawP8FCfn7CvjZT\/zTDA8XAfm8vG+R5c9vnC6Iex9oOa\/\/Z4QNSb7PulAPM7DwHjBVrtxZm6wsQXGkMjL84D02YpW7cqBjSla6Z4c33ne\/\/3dQ4AYtF4JCYEhQnQ+bwMhsjkDXrFZrVbbtf7dT0GgkOCegYcBFZw250RM8poZEIteef13kdsVgNkGGDqOlEZcVJA+ANZeeuTAZRcG9yzvIQSMqM7UrpxwOQqENikOhgITVVdZW3l0eQ0SrAbAHW93RmbjS2yu2nCDXbzmwz8\/TJsRARyUAR0zIsrDiQUtv7qI+XtPWC77hGbolIC\/jY\/R\/\/WLY31rU6\/5tDdBpjtxoHPz4ljnP619ZLsgwgoAhux0AOpXzEGgsrpg5hhzJxt7v8KAIxIggG7I90eZgQZUmSLOBR52RGAZyQuWPSUDPq48pvCaTQE4WtjkGDBRSkYQNtDsyaImzFlWivJkc6sNUZlSlFaZMlRqlX1PZATFc1Lqyzl0Kun5l1XrwsnFc2jc9kTZ0SBWupj9qxKsriwmjx5r26Fu1sZYNwbWHCbuNpcrsE5OJQYMlrH3XGqGIzQoWtuAgbjoKeyLG0HIsREeWjDSpIvMcbLyRfdwA8EbD1lWvZsIPNceqStCipYTw8i54ZSuPIHh5fUZtGM4ifoVMSGI\/4N3MkJcRWXYA68casA6d29o3Zsqrh3uDJSL+1NHktcuYFgLi4QP\/6C6DsUNWT\/YKC+G9E1b6rHoqVt7hhLsVGUmoWW\/QBkMKO4ztvqpQUbzGIUCM9wZ0IKA5CnPRuOCUwB+ZhjhZ\/n0NpwnxgMq0gv4Aqozh4yEEuxxpF2u40B32xMyLYWdeSxBBOHA1Ex7EqU5sTSgpSIxQGLzM21TTwRRAZvmMTSmhWraweyLKPJijcas0ySyMu+JMy5acpAaTwmwbstJQ3rGoUIxOQbIM\/E0OQzFCHAqmeqPvP4U8w9a7wrwQPU8GfJQcHoYE12uHrzKzFZI2+AWarMs1M3HwUVGwFPGjPUNrYMrxMvU4wUL5QkQdHUgNSk4TyUMGWw1VRlQexI6WA8pVNh85xT\/1ZjSWBsV1lwO\/YNHK3Tsdi9khoHVlyb3aJMELhc9kr1kgVULERJG1ZYabFtdiJlk7jnXHR1eHDdetIjL5sLw7LpvXdFjWRb1Zglb9R\/Uzq0QUjK7bTAfRfmyzx5mbqWYVEaizNixQpL9VXLLpJ4Mis\/UJZA6SBxsksgmYwB4YQ7ZjnMwyRwl2UVS44FYNmS3fVVKGXuAuPDClbMxyd3xFIMlfWMmecNW+WtXXP4GcRXAIW4t45SB4OT1Fiflk\/hb1d8uBuLrco6Lzn5NPpor5UetNCf0cGqMXFRdtk6oK1yoG5ebD6nw4bWVu\/AplEZzG27k37xaGLZDtVeedO4Gv8pOShi6m6DHa4YcS092MW6se2i9VODBV5q1a4SFdNbtFNWGXDGbfRNaJM1\/2LLai2nUPZ\/dxbJAXBzxP2W\/ogjHFF1wRKb9lbAblpQWVlH2PXXKSzbZOlZsdCx2L5kviJflE+FA4rpSR4ebWsoHtHffwS\/ufHz4h3Ug6Nvf\/rTMW\/x7JkizZiBPkmng8hA4jPvnaJ+PaNVIIoGwO3oKyLU8l5T0DW\/6NmPR6h7mdRa4QDdjcN\/baOZapynDw6GEDYnS0cCYYWmvhjKQc+C3wHrpbjrWXA2hqhaJ6DztON1KX180lXF8lG93X3OFcObxA8r9T6TGfGIPTSbEx9FwXL\/Bc+GplnfSRKAwm8YrmZcHFQ4Hiehc\/hGb+0YYRkjRSQlZqmDsJGiKryIxhqaiorDkuEV85E95IlOGBi0m7EgGMU8OkETDyNYIdfTAQ\/lS5F1iZdLvncNQJLKgR2DXhUfqcc\/8k+S29vfGzE0t3QxcXd1jIYoHwPGUDbSJ\/FjIRT35sdUkOxh7mDcHYVlRU5aRZV18IgGsUeGpsHSjr9Uler8RIrHuSgd5\/MPKoMUOxOOkpXLHKNHNkm9TO5ym71UBRFLpz9K4s9s18QWAzEUuaCYs0sSRIfv8uRK4vznXZ48jDEJ486BxXFf3fQmOFtjqbeVEYazU9ocRSjNLBz0\/1\/+DKcKGQLRPrXwZaFxaOnQyTZdduqbAo2GOqulzxLJ8pQfDZhJx1mLVJpSoxQNjUTnwtApqhQ25NynS09I033JQ20oBWlAsohQrhH0cBYU46WIxgeRqiqNM4Fmo4DaHZwBL48Pah5PGdZRPQVVJgdqJi3tckZOEGiqDIJEDmVBL1FkBZEwxWhDlLRUjuJTi3yrEFkDmMigAjRhZ\/XqE6RxS5x2Epnd4qXSbDrKJdCOgD9K7CqQeJZPXNFxyCusE2wpSXaCk6twDewqMgrHFFbzDNr06lC\/iDjVllWZ5aQnUbS6L6wCL0CmFQ9dU0tDwIZ2B0zLEWgfwc+V9pZuav\/l1WtfIM6bCncPfogtJYzLKs4VE67MZaxzefbZyPrWT0YlVXdDo9cGTjdLCl1KY3lgRuT2IiVDXCMbxfs68q6Tohb1nHnJ5NdLetcr7U1CZ+2y2FXOdnodAvCt9sO\/sJH0iDK1FhOEqcdBvlOKcUvwDv17Af72d8O1bO0J9asB1DRPuzYcrTUBJ09ixmm+oYnqREfsRmZaVUgTyeqH4dDhF+tYC+uwsTmaqkOY+XjHh03CJDFwWZeI9Y\/9YqNuP0zNbKJzyEYwnZEb9lMtl6e+wMws6JAcYOV2OQB8zB9r7NoOJcMNwu4xMCcjSb5SDTZ1PRYod2cs0LwBOFAnbsP\/mImAVzNnQHC8OZmg07DRJz\/nAx4u9JnBS8cAhBgNhC40V+Mc6RIwOMjl1Gl294ytwiSYUaYOszA6dCInRxrDzQv1Y1IdaR6PGqnmyfE50LsdPGu5koCyJHyjK11Oh+HLwLZar32raVvb79gdmfURn53cTRu5JMhGo4OfGN2tFRtZVwaUJ6odWJ+2rtkclUIxzy2PFqf53CwjcLhJybVILKoyf3v3u7ALbFx6myQdzrfMDj1LZQ8Dt8kOOMu6h+1Ba7ukjVGUfwCtZVAoWjzj3nDa6OdvJ6Tbwueu8MDKzPHfThvMjBaewDRmA0iTPAxrjtPIXV5pHs+8Bx5PbxuF\/yHoNtv8CQNnn\/neqARq+BwI+I2h0f\/NZaW7AOcjxbgX4p3MifscVU0MOIYdQ3SiLK7pPtg3N1r99Vp\/vQRP7wTKS7TrcZDR7FdIagPNx3Z2dT3hSK0ur+++VYC\/XQNoLwKmhWdyMkfd7ByE0EsK\/oYrt6nIfj860GXxeMiTmLeVtwDgB714BPLcmZjPRAgToPNgPBaNLQd9DjJ6gL0L\/PKg13waOD+xKhu+8pJPAumFx\/Onpv7mIWS970nMX9t\/OPYHmP16iHtTtQs\/B7ivR\/KzNfVlXcf5tQF+61lW7grCnlubL32KR6r9wEI\/AdLPq597fv3fRyX47LeAxjXp\/f\/Tov8HYU9m8VNvfvsL1q351D+\/66D3gz8K4C76M4X+24Fr46yqYz\/+Ax26cyoFhLwBJD+W+awLDJXjo8DlIjzIobwCDL2oOD+WiLXb0cCgskARtICyq8Dvk71agrlTYkEtgMC1y7u8ELwaVL3s40Gao6HK48BU8Lzm+8HnE70ODANFM6Aj7Dgf\/EFme8H6Ow3q44Zoc8LfSsJwssK6c8ACXMEjdEGzG8LnIjyISUEfu8HTkEAiS0PvCsMo7Lu3K8NH+EBxe0MdW8OguEO+ysIniMMofL2vq0OPaTdC+sMt2EP+uLr8UUL2C0QePEAyhEHk448+DEAnXMRTOUSCy0P\/44NCJ5RCQqzE\/rMzAExEL9hEVTzDLEtFQAzFI+S+cvnEICnELSjCV6ydLcypKqtFH4tEQWQ6pbtFuOvCsBg7XQSCVcwC\/OuWL0zFYJTEOSTGUtSC2oogaFRGCmDG4GjDK9TGaIxFUSQ+UqTC9ejDENxGReTFbEnHTExEafxB\/vrFGinGIMCxzFlHSGnHAPEAU5M53+uD+HiACXtC96tHidEleOSke3yFSVONgNzHn+vHEQyXyorCGZBI7ENIXbyjhEwRh1yu5WOsjZzIZaxI7EO1cPQ2dZGRcJTHIxxI+ShISjxHcChCkCS5btSBGFC\/JszC19Ch\/otJWfQNnbRH\/2tsvwZjyJPkxpRcwHyElqbkNBgZB92DxY50SjpUShWByAjBwq2sEKh8vlbsPUnUvC36gqIUS44TySYZIzlBypnjyU47OF6hSm8LBw86ILZsy5bsyhe4S3ZxuL+0yDqYrw5AJJNkv720mr4cR8N0ube8gAeAQWBiTMk0JLJsgdjLrXV0TB2CTK3UzJmjzMy7TCwLy9K8LRKcL035uH0MTV4ZTVOYS\/vxna7Rzd3kzd2kDz06TQP0TMK8TbLjzLNLzT8rToVMSwGoTSQgwL+cRcWhzk75TRQLTJK4zAxhzec6ThLwTDx0ytl0r+fsiOVkHBGpzvUUluu0oOCsAO1wKv+W7E5D+04NwD2UeMSvI88AM08sQ8+6Ys8BzcukvMkXADq3q0\/vdM37cxIlKNCm689A+c\/AC1ClUc8BXU\/3tB\/4hIF\/VAOMXFAGHYcea5UQ3c+3m1BykLrI3MoM1VDFMQAOnR4Pjb8IHdEWvE+SOMrSXFHnbFHS\/EsY1ZPeNNLdvNBrsNEcdYW6ZFJkac4KHbQklRkihYmjxNIs1VIsbcjsfFJd29EvrcwoDVLb1EwindFiW1IxdZ8GZVN4IdMu8MtttFIS6bI1fdNLcNI8Fc7vY1E5dVGnrFM19VI+NUE3NdQb81MgBVQhbctB5TQ8TVTGC9M8\/VEpTQMqZRlIjTT\/SZ1UTkTUT12yOOWCOVVGTi00TxVVVazUN73UMoVOTe0YVDUzVV1V2ivRWx3VRcXU6HzUTLJTLbNVXR3LUCXWV21UM5VMWr3TQiVWPW1VNkXWUg3Uk2RWYXXWZyVRxNTWPq2WXpVViblWIxvWbt1MY9XVacXFap3IcQXGbDVXg0PXW1XXH2PXfXRXHSvXeA2CaBXTem2oe13HfDU+eOXXXZzXVQVYLDBVXSTYDdvXg9XChBXVhb2Chn3Fh\/WviJVYJKTYT7VYKMDYVNRYODTYjmXHj53UkM1KZTVMK2WCLZVZLe0ljkXZFthTPmXZg3TZIe2mIwVaHA3Jk73Z1szV\/27dWY7s2V+NUeoM1tex2aLFT3\/90qT9gZFNRCttWmFJU+AkWqmlSJVNVKv1Aaz9Q63dWuvs0gMF2y7IWUsl1XV1VLFE27Tt2iuK2rbVUbE1VLJtv6Wl258NWiMNV1zIW719Sr7V2bi117l90UyK2ZmV3MI13K9F3B54W1dl3IB1XEEFVspdicNF3MyV1s1lWIGlU2AlVLa9XKPlVqQ13YtF3VNV3Ui13NbtSap9Ur\/lAbPNwpL1LdHVW9L919gV2dl12Nrt1NvFXQTVXSbl3VxA3oxV3lRl3ubF2efN0ejVAd91QuANLeFtW+KtWuNt2Vg90+qt1evFXhIg3901X\/+eRd9lVd9mZd32\/YH3hd74Vdr5fdn6xdb7xV\/M1d4R5d4e7FxrBWByZd8B5rACXtADfgHvPULwDSzxBVv93V7+vdrpJdkFflcBduDcVVy45VVYPc\/0HZanDeEEHOFzPVptlWCn8+CsBWF9beAXPjMIrs8Z7swaPtsbLlgR1uHsLWHNPeFk9V+fXeHVdeEiJuAjLt0kptYEblchhtgcfmENNmAOLlsg\/l0s3lgtHmEujmAv\/tslZtr2dGLoTNGONeMeRuPeBePvFWOTJWIonlopLl4qllvAfdwmtt081mMMiOPu9OGzq+MK\/txBfuJC9tgYftZEBs9F\/kHuu1vrJWT\/SIYBHkbkOZZeK57ILW3jjnhjiT1k1qTkv7NkTu4ODJbaVPZRUO7eVnZl4IDlopVlzVxluATkW2aSXL7ZXZbMXsYACgZmXCZjByZmwzTmKLDlZJYNYUbZZv7LZ868aJZmyaBmOPZkVaZlBP7lbR7aTXZla25LbK4AZCZn0+hmVP7mWfbjxh3ndm6Qdz5YdBZLdaYAdrbnwcBnftXnreTnAPDnfw6MgI7XgR7PcJ5gbUZoslBoc2Xokyzog45oiV7mAa7oUXZoGhbljJaOie7WjpbNj\/7hkBbp3CBpbTVp0ERpRVbplZ6Nln7Wl97Gi4Zomn6KjcZfnFZGnZ5pnuZm\/59uX6D2yJiu5KEmaoA2auxF6lcU6npu6ml+6uaN6lScajWuamU2Z07O6kTc6hTuau+waWIN6z8cawAta7O+atxN6yxcawtt61d+69aNa1FUalZm6rr2pbu+3LyWyb32Za7266L+akgWbEGcZ86l6sOui7PW1cVGy8Y+3b6G7J5O7EKm7Bqc6ynN7JoG7NGNZ14m7GPe6dA+B8m+1c5mwc\/OVNV259Ee3tIu5tOGZsyWbZBg7VV1bRGEbV\/d7cim7fG1bWfG7WzW7eGGiN4W1d8uwOAG3a527k+FbviTbuYWjOqe1OtuzORe59TW7srdbD327uvL7vEm7vKG4vN2vv\/0Vu+u4O5EdW\/hg+\/4ror5NtT6Fkjw7mfxxm\/RKu4MPu5r9m+DBvAAJ8IBj+UCT+cDx2gFbwX95lP+Tr37lvAbYXBddvB9hvAEz3BLoPA8tXDQw\/AQ5+0NH+YOJ+gPX24UJ+9HRugSx7wTh\/HmVvFqZvGGtmzZffEbn\/Ac92Y+Lt8eP94fB3IBZ+8ipvHKs\/EkT4cRf9Mmh7wnh\/LVFnJ4JnL4NfLzJesr1wcpZ1Mq9zsrB3MlzfJ83nGLdvHHPvMYd2ORJnMVbXPDfnM0X3IdnnOzM\/M7h3NTlvM19+gul98v93NzEHMx3XP+rHNDP3Q8l\/F\/XnQJbXS2fnRET3P\/gRb0kyb0\/nX0Sw8Gm02b6TYzdPYD+jS6Pgd13TDqkliUM1nxLSeJiXh1VJ85VV\/1UNjXuEsQ9dJxWS+B\/8OXU+Y0XM\/1S9hXhxJPLZdkuLNKqynM9650uj72UPdp+awWWxfLXZYSuRPraQftav9zLFs8BugnUvetXX725kJ34+n0DkZyccfFa4cfoX1Fdb\/Lz\/PstDTCNP50eV\/wPL8AbEcPfW\/t0u72pJtHP\/0gJf53gMeEfYU++6rJyUb4iTcFgpFEoQR0FLZ0iFfySD+64awDCG13TmpmkofOs3Q+GAJKh\/94kA94kR\/5E8y\/k7ehZta64MJ5qpqIGcHKI3dz\/5kHA1EXP2DS9j9E518ToaTnwQgn+pt765Abp37vTn2menbPU6iP+lwYbQu5SHuHP4bOhtrr+Y7h+q5XvdFmt9qr8DXfrBw5e4ZJe7V3ugEHt8Kb8k2XND8zKyate7tHToEvueRMtjHn+0pDOkrL0cAX\/L9TcWcEx7m\/p8Q3wH9sMKeHPRB\/\/GPO8qOHTnVkzayOuxbRfCHk\/M5HTcIHu0iIy8zcxrCeM0QsTcdX\/dWneUKx+eo7fciLa8kPvGTcRtu\/\/X7OdOHsRBocfcuHg7IvJmInxtQv\/uML+mHAfAA0SF2k7Lz\/M7GfTOm\/feqXNsN3Q8nsoBIsva\/ktbYk\/v\/ph8HVMC7gx5fev3XyGj2kOMZb2cqvFG4ICHLSai\/OevPuPxiKI1maJ5qqqzccABzLiTA8rDkIidz7QOLAKNxwxiMyqTw9CoLXD0azLUkPHS8aPQwK1S84LDYVXFnfoThes9vuNzwudmmlh5ra3cTWfcGhXKDgYIbTwZlWUA2hRBPDTt\/MHyNlZdvVDmJPmmWn5ydo6JhZ5B9VnKFmnWJXnugrbMYeZKSM0Okg5mFtzF1XLHDwxBXDbh2ncLLyMvOak2rUpJwjFK+iV3M2IyZ07Z9rYNMTby+g9jlqcfcmOLr7O3zzVXXt3VD7mO66nxBR\/L8SfeS2CLjHqMCjBPv\/evwp4AAgRBYIx\/FCFvEixoxxGCz0IwBbnAfqBk7Bp\/EkBpH0Bkb7WEllxxkuUdKU9WygEJM1d\/LsKUvHyj6sHsIhZsybL50+ISI8ynLVHZC5Boy05ovoUo1AY9phoDQr2LBaD3EFUsNfHKAk+30Vy8xBgZvkFJadgnZqJpwG3cLbE3RVSb6CB198AHNukAHTytCyao7wua1zhVS1qnjbxLJAckLOxo1kwbudR5NeJpBcUjlNNdstLYxa3aSnKzL4dbByvbNYXYdi7FRoVN7Ch8eS67jtl6YsaTgkDmoea87D+OhFns94xZnOLSkHLXo7+PCqE04ObT3J7FK+xBNK\/w98b4XMax8Pmvg30a3z7JOsxhl6P4ABrnHYXItMg1speAh4SXeofaQUgdbUsJsgEXqj4IJifFZdhh16aIQuaxlYVH\/WBPbhEiVm10oHRsU2Yi4qqgcjikZI5hguNeq44wci5eXYd23ciNQQUvFowizR0ecBdLHVpt8X3DiZ45EjwIYYhlVquSUFjjSG1GUhUQcklyRgVw98IRhG3mQMUGLYmERCuaWFCdpAYZl58ugeVFm+IWOCS+p5gYvlUWllKv7ZRgigffgS5KAS+PaikZFaquOZkfQTSIMSQhppnUL5mUKmjgoaTjHLaXdpAIaoWimrsXoon4n94OnMkDOGaf\/ppG1+eoJ98\/2qxyP3RXPLrVs2it9Zsjq7Y6ir4JGshnGqlyaXIZYHKw7RJjIqqr8BtyiXjCnJ7bPpCnilVTQyyKaEhx65rBaPzikCu0iBGxK9PyjERZnWvjesugXvJ2Wb8jrzxIvk6ujluQNiMeW9AeWq6ZN7UiUuswob\/DGAcH6pnscalnrMqR4KbKphl2zo2EsnH+vVwwiKSjDIOYuX74wpj2FfXf99yGfHFa\/AM3Dm3cbxsUpnGKyvOktd4zOabXqgsS2VDF6nFzaXC0evVtKvv+6yJzNB6E699sFqGWq0CkQ3vSt7KjFdts9FbSzsmxf3STfXDCuqNtuF72z\/s7RewZ3Cy0TiPJq27QLOiAOkFMhiewlZjTlxftXVkOGhe4g0YGavAdfK+NG8XaIOErF4lGQzNMWbtFq2XeozPy467537rfrWYLSur8OQUzVy6Xm\/9PvMwUssuIPOg9Wr5LD3fv1gufsrhCAIaQbA1aVZfpwyaPOz+kHIm0o4WCq9aj328btF+jFO\/8n89sovJff2+8ICcXmwNR71RaMh1PKJ7BgiNPkxcEHD81q4WNMsvsAlVd6BXwRBMzmsSVB6GhFHxBoowgUZRUTsix3i5oZBz6SwJQJkRgm3VbsW8mNC04Me8U44wh0KByZBe+Ea8He+uBwQI+ZCTPj6MrEC\/wHxDQjD0QqBQb8CFiSKPLzi\/mjIjw0+L4Q7cZWvrPgmbx2Li05s3LXEGAroaLBlWHxjyITIkPyM525lK15EClW9D8pxE\/5zYgJjoIghFBEd\/KuhDuGoSN6YDw3og0PXEvS1wozvQh58RyM3ob9LELBeqwJIJG+mxkWSkiYArFUTw0A94uWxj4K0X01sVwrQ3YYiZPpHIHuxwFLy8mxaVOCdQqKOoHHOkHvD0u4K80uZ2GCUVljmKy\/5iiOi0pm9vOZJYtiuRAakDHb0iDR7A00Y2Ess2mQlZsbJCnS4sivJxCY8O+Ojb86AjmnB4Yy46YkkIXGTO3kikcJZhUPO0f+f+9xYw6wZz4VmhI2TMWO1OhmFTwpDe+dzI2TQ+B5LWFSB+tzGOM0iUIaSlC96JJ5COSBLoRi0b\/hM2khrMsX+tRQMJy2Fm4IBNCZ+tKQ+HUwmbZFKVS4zMcLIpR1iisAf0eadYSDjJnQq0bKl9KdWjchKAWMrVPQxATn9XzHo+cqhdoaaQKpqj9zmqOKENDVXfWt4oApOjOrBogB7ReRQerCQ0kBxICXLMUTBT1T2FK6GNWcoi8avStYTooxq64MKyRtqkOREuSDjAUTR0XqS9bCezWg7N5Oxe4pLOgeF14VqOtnQsgKtTPIb9zxRBnW69bO2xd1UC+paDMDlSzT\/2C0JNitUHgm3Kxz9kmlfwtc\/3ra5xqPtLt0wEQFQV7XPE6sdmLuurDLLukuoIHWpq9SBLte7zj3vDRWiKOBawDDsFUFiqTje7TyAqRCU7IDomk4vore\/wznntQqbzfLqt0p5zSd+s\/JATT3Ivw52jg95+l5QmFWvoBqmhDNaYaH0VcAP\/rBP3KdBvsR3C5018HId25PibqaZIH7xf1lbW57cNGnmrRFBOTtfd+RYkDOGMZBdw+Jv9MShlpkwI3PLWSQvTVU7DjKUs8ldKt54GTI+Maim7C9afrG8To0ymJeyYEdp15Al9oNlpSZXYD4gwefQKFSqHOY5m\/KYJqJo\/19SXGCdAZjDeAblS+P8ZToTusjF+uGgQ4E6W84yiaGbJ6KZHCWEBlDShb50LNbcWHgE1Z2WDpCmowkQI4Pp05g+tWApvUd5hBZ8ZS5cjf9m6qMd+m2ovrWQlexjLFuC1GnEYqdFm+ixWfDOHsY1sk8C3s8lF6wHwK5ZeB26Zffz2JyCLB6TrW3BINXVwUx1sb2RZjh2uySz\/sCGtfrIbbMbMmee3Z\/fhO02X\/Pd9bQhLIbMlnbzG3K1hmKvoSYhOV+vx1158hJi3d1z97vhvWbsuBgeABaDb90L1TfCkeAAvt7V4R4HrTr7+mmDb+bVpZxpDQkOon+nNuMff3k8qv8WxnRA+18qjqfMozdyO4s73jD\/+fT0rfLgQjvawyYlnFVnbVLNG+hOd7eX0eobEbn8jREe+CRNhloOO\/rpXneLvQU5bvRANuvOFXGBli4CodP7624XDMlbix5VY\/3Dcf8xEu5u8rfzvSYY3zMK2B5kto8S7fHqO+IHc8qeD33igQaexHmHcng3fhgYxnrkE6951Tzek0cPAGWxVPWfjllaCO+zoDeverhThb8i0HPm5Yf6RHgVdjlvauxXr3snetnNU09Y7hsIaZ66eTohj+7uk58Vw1sSv95jSbNRHWopmG4Dglc+9sUy25rj3fjcR\/6tFa7CFsl479k\/f0YI397\/6\/db6MMKuxTGjv750zjdtE\/iEs\/qcWpXk1Cwpz8AhkW3PQrd6UrwwdMAZon9FdBWBaADgsWQBUHRmZvXwR8QMEer2BfGfN4DdiA67NRczJzbgaC+fJ\/FeSAK\/lNIyYnm+dpTQMXNpaAMUtIKetIJvp34veDBHeAM9iAYqNUL\/ssNJt7t6WD8+ZwPJqFGLKCoSFsFUtxc8aASTmGKQNfoNVy3xd++USEX9oS90c4DWiCRdSEZFhnzdJgUgtgqqU4alqEbahxjjeEMQpwmteEb3mG3HM+zPdto9WAORh8eBqIRMQAhcqDynQwgCqIijpp7lWF9mZgdLqIkTuIHCAAk\/1IiJmYiM1jiDySiJn4iKFYCJzpSJIaiKQriKNbhKa4iK8pBKgpVKbaiLE7hK5ZDLM4iLs5gLZLTEOaiL\/7iCOxixd0iMBbj\/AmjJxqjMi4jBSBjLzIjNBajMxJjNFZj302jNWajMmKjNnajL3KjN4ZjK4KjOJZjKJKjOaYjJqKjOrajIrKjO8bjG8KjPNYjF9KjPeajD+KjPvYjCvKjPwZkAAKkQBbk+RGkQSbk7iGkQjak5jGkQ0bk20GkRFak01GkRWbkx2GkRnYkv3GkR4ZksoGkSJbkqZGkSaYknaGkSrYklLGkS8YkiMGkTNZkf9GkTebkbeGkTvakYfGkT\/8G5U8BpVAW5UIRpVEmZS8hpVI2pSIxpVNGJQ9BpVRWJQNRpVVmZe9gpVZ2ZeFwpVeGpc6ApViWZcGQpVmmpaygpVq2ZaSwpVvGJZfApVzWJY\/QpV3m5YfgpV72pYDwpV8GpngApmAWJnEQpmEmZmkgpmI2JmEwpmNGplhApmRWpk9QpmVmJk1gJoA4QBPERVwsAOw4gAKAZmhSo2Y6IGeyB2kiwB4+WwMYQAoogGu+ZmymZj6upniQZmMkAAE0AArw5hn4JnDiZj3qZngIpyD9ZnAqQG8yp3HKI3KCh3JKAXSaQHUCwXVGZztO53ZkJ3E253MWJ3d25yX2DnhuJwn\/pCd5lmc6eqdzsKd4Dqd6uqc4widxyOcJ6Kd9miN+Dgd\/lkCA9mc4\/qdwDOgIICiBaqOB8oaChsCDLmg1NqhrROgHWKiEMiOFlgaGdkCHZqgxbihpfOgGkCiI\/qKIjoaJZsCKnigupmhntOgFyKiLjuN58g6NVkCO1ugpwihk7OgEACmPgqKPEoaQBsCRDmkmFulgHGmSKiklMqlgOKlz0md7QmmI3qjoUOl4YqmGaum0VelyXmmCiql1kqmXfiOYGg57upebvimcxikCdGmaZmknPqPOsKcBECKf9qmf\/mmfzqmV1qmdkuL1ZOdmvKaiLiqjviYihCehAqOUUpCZ\/xqhNdRnpMripLoFolqqUGBqprLipopFp3pqIoBqqPbomhZOqZqqv6Bqqp7jqrJNp9KFrd4qruYqXcwArMbqJ45qWLCnaQ4rsRZrXAyAoI6pr84isIIFlYbNmS6rps7q2nDpoEqrqFLr1FirsmLrKjZrVnBrtHqrqt4paoZrpUIqdqZrr5LrIoLrUoirdqKpu0aptkqNvKprvWoivPpEvrbrvuJhv\/bEv9JrwL7jveYpuxrshS7swfJrwuZMwT7skkYsyEwsxdqruR6qw+5nx2asJA4sT2AsyL6rxX4MyZYsKp6swaSsygosyxaMy77sPMasuswszZahyO4EzuZsF\/\/ubE30rM9SIdDShNAOrRIWLUocLdLuo82mC9M2rS4+7bM4abLGwG+eq9TCmNIqG20qKgHIpse6pgQewG1u7c9SLdTC6Qp45puiLRl2LdxGptzObWPWrd0mJt7mbWHuLd8Gpt\/+bV8GruDmJeFyB1UUotYW7kGqbYCYwSA1UyMybjkebiVA6wVKoHgZIuWaouVSAuTSVG3EBeB1Loo6bsgADTTQhT1UnukG4uf2DSGG1xMAliQ8W0GMLue+rs6i7l5VV210gR6qV9P0Ie9m68YOCkf8S6OSBfGi2R7m7hUebwfGbi5IlK1iV+S+zuRSL8Imr55Aobj9S3VNr\/cqn\/X\/TsWhPa+rih3uBu\/uni\/6+m7IzAI9se9TDNLiyu9M0q8DHQ\/DrC7zhtez2Sqa7C\/\/Olj6PocOqE\/kDgAEPwJ17SH+yoTaJfDqLfAazVbtPqrmFkQzHWvizu4EH0LHYXASavBiQDCxGgZWEEMAPyofFtMwHCshmi8Ku50KpwVZvCbw6i7peiYJZq49yIub5jAt+m94YK77+jDwAnABb1nr4jASJ94OwwETL0cQdIQpIHAVK7ASc01YfU\/+ai6efvFAhnF4qG77OsoFo7EVq3FclcHwMgvw1m4BG7C\/nDEco98VEwLqFIvt2sEdgHDiJi7tKirr8nEfZ98fj9H2CbA9\/4DEm5LubBlvI3vgI7fBbLEwaKrBZ+rhIJNv8OJD6Wayasrxf6kD7oZX8ELwKcAwxwzSG6Oy7m3yGPSW2GWvopYwBXcD+cKSLcsgLotB5eja7FRwylHxMMNcMY9C57UxXTByMyffM5sMUAwy9DpqrtZBg1Vz9aoyfXkJx0xxBEswAd\/qJsQvOF+kOM\/x8A7nBxfJZ9pwn9Ku+bWz6l1zPrQDd3WxF+vzg\/GzTVEFC3cv6G3fUQywEwq0H79zhbpAK7uyJx9rAOPNQTt0DxJ0wo2PrpatIksx+Gl0GoNvmQTbZiyEGccgSWcwRLsGSj8FErb0Qr50aRADy\/GDIsdE7f\/BHR2zM01rCUdrSE77GD77svOqczKqYO2aR0AHNSjdBxc8tTLsQQFeYBG7F2jCMiJXVy1rw8TwMjVDdbZwMDCPtYFtjDazwqccsWBksS2SdboQFBcUX4eU7mDdm+tilTBSH1XLtRRBsR2sAy3nSQPjM59y9frOUVbHqEWhIWCXSV6bRQD0tSD51ZbA9a1OdBTnDzMngwtqTWSn9WJ3xQ1YtlF\/NWnAdTLrMQMGR1iQXMmx9Gj\/1x6M8RydAmozE1BDRv61MRB8VYhddYbVNqhtRQV71V2Em599driu4RzFsDLLgAD8dY\/U4BYZ985wMNPIoaTQFiYPjW9oc8nRrgT\/L+oWLzVE2C9wd592k4YcnXCXsN+OeCZxy90w3ABOQ7B1qxQyz0d\/v3fcTJcd4TehJOBeyxNCsNxKu4JbyxRx44eSOLeAZ5r9xsRUe4AFmkVvh2ucUsBqqIK9BHgHeJOSRPMdVbj2lbaoXNLvbRMJHfYPw\/I9\/wYpdzheSbSTvA7P5ZOK19\/xfE51P9MECnPg8ACSg3T0FrVRNzQM9ThM5QFAXQuF\/3j3XB5qoHV8HF+V\/8M8ADc5qfYnTB+HF5h9\/7c0WLmXc3fRidRoll+Xcxpzm2pP55HApRbhyPYkqzk8tNoMuG6wcRl9bV09oXciJDglBLp6g\/h\/V5yY8zkb\/zDGRedv16UA\/4lbpU\/Wgr8UKSs2oIqXdcM5lGiZZ5M4SRsGdItNFRZ5tvXQMMnwk1DLKTcD6mQN9Gq55bH6rEN65ky6ETZgwomhe08WOcvzOtEEHX6Lk3cJUilE9fF6OHA3GV9UPuC2\/lVoPRPBQ8gy+25vfx9YlLPA3YU3tKeDBhohBl4CHaxFnJcPOlM0jQfasePSnJNZhyfdzJh6FQdyB7evoHMyikd3u0vRq\/Oyo3bMO1RQZ+N5sHtZuas7dU07DA4CxW2h4u02OQz5m9F3FRThBtr1w1tBA5M3nedzsOvbTK+YreNqvZidMlxZl7+44+h754YydgcYd6QYjv8\/ua83cSHncfZ+BMink63D28CDHpYHys7zuT5IvJ3EXujd2dGPOem0FqoXa9tV9f+RCJfT\/NzedsB7qvy5FPcteyuxeOR68aKVvcs7kaiH\/DOFvakuentU\/NSLQqMM+1ExGgQdl5J4fc6SM8mD+dh\/gsK\/CK7HQ\/cKvgzr\/RpFuA0++oATOu2FxtBXOKpTPpjrkuSrktxf9tLj\/QgDKuL8+\/9w\/D6lGJLCPbOz+OYXVOc\/lczj\/BdlwkdPN\/XFPhJcWeiDCJT3SdurOaoH+eubHo9BltmXD8ZLi+6LO+RvmckTQuhiHrRPXvHXXkCXW\/S\/BWtn7u0nhhSSOQWaRrL\/lxGfS7vTozvdg\/bbL6HNKELukv7dM8md075nPH\/KNX8C52DxQwCQIIkRcNabd\/\/BUASfQUimVFUP5hnhWJ7ngjnQtBpe2v9jhdOKmGoVgEmlTJgrElu95ZRatV6xWe2W2\/V+wWGxxiY44JxP9Zrd4o3hnEc5zU4c43nygGF23gUYkPSSHExw2IwspAi55vrq1u4EGRstLzEzNTc5Oz2VHB4ezRJLTVcmKz+1bBBNKwoGV7VK\/HTcRGfJbiKfElJ1rR54T3dyg5GTlZeZm52VytBOp18FClSfgeZIXw+ss5fodIyDB1xLU7HBRUpuimHX4+Xn6evtQ0r4bKn5Jb1l\/+\/RGHamV5EKlAJiyDeAYUM+54y4+NTuQDFvbxKyO1SQyCSMGUGGFDmSpJKBHPullHDnQskYJSDaWRTw5JmYTw581HSy2DeXH2CiRJXzZ1GjR5E6a2fmpkqnFGYmBbqxW9R5A\/sdAHjpUVNfgbZKpSiUBVipZ9GmVZsl1Ninb1FJXNuhFtlbCOUNQ\/mLr80zDDiZsDthUli1QiqeOqJubmPHj8UekgaXMkvGc+cItihoXpOhDByG1mmJqilckDEUOLTZMGrXr2HHG+WVssodsTe0GrzSwrV4uv\/gWdV1969AlzETq4YXd3PnzznV3V3btFzoXS1ayFsr8cqLDjyZm\/9+8FjzVu+0Q1e\/nn2YOd2pwwXWfti+RIWRJ+MevHd+MPu7Ac2\/xwBE56IB20tQwQU\/GCK+t+BhEKZpLKNHM0VGi+O8nlqD7kIDrWNQxBFJzMCzB1MqjETiqsowmMwa6sO+CYjKwwHgluvwOt1eOUjHEoEMErYC4EPRopaCLK2UxZaRjCC+IkkAMDhC+fC+KILk0bRFwBPSyy9R08vIaf75MjMHQfwxk7ooIKtGMQyZ0R\/mgKQoO9\/AzFNPtE4cc04EFdRyyf5mmRCVO\/wSwCz3HiqOnDxPKg4sQPes1NLfivQTFWsoVRC7npCciIE6DhrgGlFQFYOnanjock+sQO3\/9NJZaX3RHU2h8GnWAq+0qhNBAXHxi2iKO21XJe04sNZlmc1mVFzvajaAoMgUNpM+KXhTjNV6khVIbJMNUdpxyd0E3DEfbZZFA49bRbV9jBN3C0ET8Yazcc90dNFy+e03D0M1jZBfxKZj8hNwsdwi3x4T7ndVdBbx1t+JKZYBTSNzUrPWdzNVQ8VNMusj04axEKxYOh1+CD08K27Z5XAupu42l+sreFJL3lXUpijlXcItdq3ltz7aNkX55aORDoFIFEmm+VZWG4F1DW2pePi+9JKeVjkDQ83aa9jaemCBscuLQ2r59kWa12R9VfVp72xSVEArxMlRYmZ\/7jXor\/mu\/xrVsn3++2455jDA8AEaSNxwAxYA\/L9n0S7AVa\/ZVOzeMW68uFSW6Y55To1fPtdjg\/sunYobEU9c8SkcUCB11Q0YHHUGEifA9ttxJ0DxBeAwBy7hSh9lvKbBsJL4KQi2fO+kF0bnY9OhB8IBBATIvYHBA1CAeuu9DUW1PnIPP\/wGGMf+Jd9tayH6XYhe4SLJx1j1eZ\/rvo+89eXY+mpTJ8fffw+mVz3cXW8J2hPg7QhIg9aZQHwNFB\/5zBcDyPFjZv\/bxvB0JYY+sYQK4tlMBCu2Iedl8H8l1EAAuVfA7Q2wUzcCnwNhOMAG8A4MovMHCf9HrAAtTxgThMrd1nZDHv9Gb2gnG6IJv4ZCFqrwgLZLYAymx4AYTtF6NBxWx0Z3xOChrxtaTEI0WODFDJxtf0jEhwe7CEIzkkuJCMSeAVMYA+1J0YGwW1ziXvhAK3rBh5Jo2xqDODqsZaGIv4iIrOglE0H0b40byJsd7tfI6LXRiW9coRuhiAA6PnCGewyA9\/hQR0\/Oy3OfkaQHpGM5zlWNiytB1OVgUKVS+gJ4pwRB8tKkRltaipK6s2QTfRlLBeRxgOX7ACiBicBRaqGVHfnjLpsHIl1KLVim6hQulzS3XWpklgap5TaP1ssnAgGOSxxBOasozFA+8HFYBMB3wOmBRE6NUFQQAmG04oNHSiL\/kvEUAY4gZjR\/9kucv4xjCKKoxxmgc4DL1EIfJZATXZruU1CrwgD+MKUZoBFiYoynCDs60YGOqKBMPOgxXZfMGfqAocqsIUTSNVK6iOxkoGPH0443UzmNTpsyhUEgaflMny6rpEpo6Tg9MMfxOVQEC1QpU68AsAqI1H\/UYlUEJ0i1DrjQnQbB4VBhYKVwOQ6ssypqEo6an5bqrhA2EJ8BxDCq+ZQVKPOkpVZ9gEaBycGuX4ElXX\/6Ln39FbCVOis5L1lJhLo1nWhNrBOhegV99KywGgAqTgQ6Au4Q5quiEOufKvsDbNarN4wMrZAO+4O0huCojAPFMMcH1\/+k6rRA\/7ngBwWytb2O0WSqNG1tNQJRQa4SuCVKLUsfi9QNtG6TLjXpSYuLM\/214Waa5SIgwrJPQVI2ujclSI66C6Tj0mC1x9Tk+E533saG9xJ99WrXgOIgWKjCajKBL3tlUF8\/ehS\/jxnvQpN7mYRarwqwXW9\/CXHZjlyEHQ7Sqg5BxF8EazeoEkZwWv4rg\/ImNbmR1XCHL8yV3nJNR7CiGmJWFuIlfJanZFWxazIsxwCDYJjAXGl6kxm7Fye4fle67xgFsBKNuhcKPd2xPgXLMMIe2b8zNqqTt1rjA4OCsQ1lsh620b6yCAujErBGj8d65XBMd79UFbM8YgyDDXPAhUutAv9zbezhM9PChpg1DPq8oWUWcHfOUATp1czc52eIcwprXm6VbyfbAhNTd3IWNBbAPDXSBaDLbSpWbx7tM2T5ETSZPkuazwllNqvXuQUGsafjR2aPzSRz\/aggqk2ialpaGNbZECfjFpdrXe9a1++CrgaO6mgZx7nWqmpUVWLRTb8St9gCOTbQAt3sTfRSd6qz9rWxjW0GNFexHCa2FVorbUadQFLKXvCSxS1abuQy3RmhNhXhPT7GBPsKt273F4TXIzIZ+d5fZDEt+dxvZ7w73gUPprenvARqK1rgXBgthPrZ8DHrmTABl3gyCG5weCs3A\/S2wsIv3oVQmBu3Ia\/Cn6f\/ZlOTeyLjGp8ixzHg8Tc\/lgAMXzmkReYUj0S73xyzC15vjoyWuxyGMM\/eqWee46A7Qtb2XToWKqcGiT59Gbfm9dWxvk5zdkDmOA6fzalehXUFFH5hFzuRp272YBD6uZhEuJXBnVywq30Kqfwc3bPwcBrRGu9eALUIDH1CUt9O2GpGet\/99u+ILhLxUOeoEfjeeC38nbWiPjS3a67Grkseed0UAM\/pLib3RZ7z9bY8cm3MmDYnHK2MvnHpO8gRjcK+asJNO+0vQXkanz4DcGb9D3wPd9wrodJEmP3wkyD6MIIe+QjlPYBTT2PXF36xmH998\/Mqe+zHuhe33z6Vnv\/h\/+h\/INzp5Tb5vv+D4q\/g+Ol\/ie1J734Z6J784f8kzRtg6m\/LPwbrV0H7+Q8f4I\/5AvD+xs+xDnCrBq\/bCsj6qE\/+\/C8FALAAUWkAKfAL6O\/t3A6ADEz4CmEBD+4CQSACJ2ACRdCyLPAEtyADuc7+ju6p2s6J8k8FP4AEJcAEaVD5II8AA5AFOSDwlgv\/HnC5OrDUaJADbBAAcFAFdXDveJD\/fHADgFAKGS0EUU\/ejtADknAJT7AJIyr+srD3XDDUElADEUjHfGD1cmcIIVD7wtCRUvANvW7rEKsMowzzGi0Npez3snAL5RAFuw8M3zAKgW0MDVChoM\/N\/lAD\/HARtf8mEJ9Q\/gix4wwxexhIEUfAqdjJETOgERfRC99JEMNwEmOuEpmrgSAIoVwomfKQEzHAE\/8QFL3PFRWoEnfPDusPD53ItdhMAb4HFdkwAGFRDmVRFLOQFF\/w13ZPF6ttccZmcbaNFXVn7hZxGN+wGCPR\/ZBxCutPGokO\/WixE93wE+MwHGdgG22x47SO6M4wG+nOGsMQG80xDdPRDK3Qz6rQ4K7PHOExC+VxHs+xHlsQE8\/RdfIxhnYHIMXxCbhQBP9RIWOpDAaIdRCgAWTobhboIMeHfIJRBfvxCB8SIjNRbMaGbE6HJEvSfEShAAzgdbLNcExSJF9xHGOxHGUyIbz\/ZwFyrSRvEglpkhhtsieF8ig+MgeDciiRsiSKkgmPMimdEiSWsgub8imp0h6i0iGnsiq1Mh6u8gJDcivBUh66kgK\/MizN8hnGsgDL8izZUhnSMgDXsi3lchbekv\/ici7xMjB+8hqzMi\/9kjT2Mh778i8JMw7qUv7usjAVcwwO0\/0SczEh0wsaM\/0eMzItMwsm8\/sq8zI5M\/YYkhM3szNFEwgyc\/tCczRRUwZKE\/tOMzVdMwRWs\/la8zVp0yc\/0xFnszZ1k9IC0x8HczeBcyZvkxwhMTiNcwR7EyR\/8zhrMzaRLzeZczSdc\/igMzo7czpxrzqt8zKxk\/a0czsjszth\/+87wXMxxbP0yLM8C\/M8OS891fMv2VPy3PM98zI+G28+6XMu7RPx8DM\/23I\/+64\/\/fMsARTvBHRAw7JAQ285EdQ8k9Moi7NBX1NB1e5AJbQqKdTsLPRCn\/JcOAg3GZRD\/RJgnBA0Q1RE8ZI7\/MJe3DHoNhRFh7I++iAa5Ubl4PJEYbQta0FReLRGTTRCc\/Qyd7RHfRREgTRII3NIiRTdlPNIkXQxlbRHmRRCocAYn1Qmo5RHp5QpnfRKCTNLi5Q4q7RFvTQeTYBIw7Qmu7RM8xJM0wYo15RN59JNt1Qq41ROdfRM0bROsfJO8fQs6dRG7RJH\/zQpA\/VHx7RQR1RPl\/9UUBGTUBVVKA\/VSBM1UueUUaXUUR0TUi0VSzFVSzWVMjm1UyFyUsV09MiUVBHzU9MUTitVVc3SVNX0VWEVLGXVVVG1VmOVVd+UL\/1UV2OUV\/nUK0cVWF3xVn2VVo31KZFVMH91WT0VTVs1WXMVWqmyWX3zWa1VIbG1SZV1WyVVWENVM4sVXM1UWnvVWb\/VXKNVWoeVLMuVXXNQXBG1WuW1J7uVSu31Xtt1T8fVNOOVX72SXil1XwWWWwn2VJfvYPu1Uet1YRm2VBN2Vg02YsMxX7l0XS0WNCcWVyF2Y80RY+1UY0E2FjuWWj+2ZI\/1ZNW1YlXWZNH1XdUyYF9WNln\/NltJtmZB8ma91WV11h95Vl9T9mevMWgz1meJlgmNdmSRNmkdcmn7NGedliyhlli1dWpXNWb\/lTVpFmvvU0b89WF30GuBVmvFtkTJdl7NtmCHNm3JsgyW1Erls2vdlu4MAWwVRW7n9mrrljX5YNtAY2sBlm\/7ljVjIVWX7kULd3ETRHEZ93Gvg24hd3LVw3Ep93LDRHIxl8lW0sW00nI3t2K8JxZioXFYxxdJtwBMd7H4YAB48XRSV3URN91AN3QnJooAl3Y6khJnNBBe17y0lBr1UJNmlAHQkGnb1nZtKYCkdHdLkUj3UQGb93RqLHhnV9pqV3n5hXm11HlfsEej\/3fUpDR8Fah65eZ4o7ZptReJuFduvNeAwNfD2td3sQfOrFdox3Z9t2l+GeB9qSd+m+p\/pRR99RBvjfd6my179Vda+Nd\/oVd+BRiAC8F86Rd\/0XaBT6mBCy2CBYB8Bc9df7d8DZiA4ZVwMbh0NJiJJBgE5vd+gY+CD9iCvxCBT9hLUvjJHjiA0TUQgtF+z5eGa02Ba5hWbhgBVxh4d9iDEQqGSXhmTXiIvaaI6\/CIAYiDl1R4l3iEgRjWhBiKeYmD+3eDc9j5lvSKW4iJtxjVutiL90SKVYuDlRgD2hc08LaDH9CHK\/hok5eNJwmMHZiKpTd49aFHQ7ip0FiGQzGN+f9YQdwY9QBZfIO3ADRpgAEFj2NYj\/N3kf2nkckLjiF4gCW5jsMYig4Zky9Yk9eHk6HvkYNwfBcAfln5DikZkWcRlU1HlcUvlsXQlaPIjIVJi2lZb235i5f0j3k0jg0QgGHZhbN4lk15hoc5lf1YjHVZjj35\/urYjjOxlJE3k6MZhadZhY\/5kyV4jtC0kHsRmJ85kb8ZenB52Ko5mcdZjpf5h5uZmdN3j9sZaeYXmckwnvvZinq5mO\/Znte5lvc5afg3dgSnoR26oesZmQO6ELMZnXuPm\/PZmxM6a\/hXNDz6o0NjkgH6mgtxT5uYntW5m095oxXainP3pWE6pl8aTSX\/mqQv2qVP2pJPelCfmKUZ2Ip3OKiFep7JGJAHmpV1WpEzbY19OkFaeKihGl1reoylUKQJeZmSOpiVuqkh46mj+quJmoVt+oTqOY\/JOqUzeqW5umW8Gqy\/eqqR2qq7N52dWaWhea3DyaVBeq9Fg0bDGon\/uqor2pOy+qCFGa9F5J0Nj6oBW1E8uHVweo8K267ZGbFdZqLF2bHJObAvz6TPuq7T+q4tW3TDGYdHmrEVMJtfb7JDu7JHm2IU+585G5JnW7DPmYZY22ql9rWZJbYBb6yrGLW9zZdzu4R3m7drxbcrT7hpW7MzUa4dG66K24mPG7nNqrSNuLY\/OJ5LcbCz\/wetRVBzrZuRsXuKtXuXufuTytp4p\/tGe3q8v0S5b\/G00\/uT4DZ+l\/mSRdCGpGSr4fso5Lsb6fu8R02UY8eq9VstFU9KBPe\/E7u835i5W7m+n5dIDQfBd3r7mmAvvsrBiRjCHZnA5dm5Vzl4Mdy\/d4zCVGC3PDy5QbyTJXy7RbzA4xZsEzz9Hs9jLK7F8yTAh1vEMRvARNnGMxz2IKxeGpzHnfrFS5zExTrGl3uHbxz5UM6PlPynCTqztbmoZ3yr7tukURy\/9K7FrrxZfLwFodya03wZY7bIDTTJnEdZyry3mTyXgRy456+sDRr3FO\/cTmXOzbzO4fnO1zzKfXk8n\/9Nb8Ic0EnizH8Qz5t7y6UHus16bimON36M0T88y02b0Cmcwwx80QsrUuxG09lI0Bd7wJ3cscDb7KrkbdgmyU2dQRy9qtc8yNuq1cNuzDHrsGf9Oep5lDt91YP7082LyEVdpsYOknLq15cl2I2Z2AO5yw1ZgKd86fr8M5Ld2V0CdRzCzTNRNRxidVnYdb4dhDKSdsC93xTsM3yd28OrdVTDovFh279m2WVC1uH9ysJmBkImcJeaFySF8fadOge5Ru29ZTYrQBK+4E+LVbdN32WK14tg0hzeO7NZS61JxVR8wdrl4pvvy9313Usox\/0h00G+9ETeXQE+vI48XEg+5YP\/OOPRdeOLq8p9gcVlHvl4NWZNpbb0a9V4oOF3HrhsgOZ9ntlGKtJ4SuKL3uSWAqwz66PITZWeXi2\/R+pt3p86fijS9erdb+WFuuXByao6CuyZMOu\/ettiHm8gwYiIHu1VTO2\/euuRqKL0Ru6vke6hOuLNiMg2Zej1nhj\/VuuVPomY3iDmZ\/AJH+l9Pu7nIttX\/JsYPxb5fqgD9wF+i2Y2TZDavvLx7ugNn3IAf8UHCfTD0Xscf+Qh\/ydInexaH\/VR7XtWv1FjPyQWnl2cXvbl7\/LHXmYtpfQj4vB5fx7bofal1O7xRvi94+OLHymjfu0\/n0Ak\/y5u\/\/nbLWSknuwv\/6XdJ5\/fsD8pZ8etlR9MRKHpDuX0w78qHwH5NX73CQT9A7\/s1j8saV\/qD9dLOIY16h8Cgpy02ouz3rz7D4biSJbmiZrFwAjuC8cuU6T2jaeFkCTADwwKAQlBLYdMKpfMpvMJjUqn1Kr1is1qt7nHqiULzwaFB\/eMegwEB9\/wTTwIaA60\/Y7P6\/f8vv8PGCio5AUmFsYwYDaI56DWBgeXcDDAaHmJmam5ydnp+RnoxXKISLMIGvXQ0hM5NJl4iio7S1tre4ubq1vyRYpIFrtbUgjZGjQpUCm8zNzs\/AwdLQ0i6vvS1jMXPI2hWmwMVKTITV5ufo6erg6lxmAY9o08rv9esAp+fECzvs\/f7\/8PsFk7MQfevDpyboebez\/yIQwIMaLEiRQrWhH1js1CVw63OVOjkWGcZA8tmjyJMqXKlPUMfZOULECdZw+8bQQnbqXOnTx7+ozmpZ6Ll5LkzGNm82argx5\/On0KNapUPb2UFjUlrB3RpUanev0KNqzYJY9ExmHQVFa9rUtjjn0LN65cuSCtRpKD1pZQuwYPOJwLOLDgwToVmgXwV1bdw\/nSEn4MObJkaUILimTqCSTbq0cne\/4MOjQtm2bF1dREjK9Bt6Jbu34N+0\/qyzkxJb1Mcmbs3bx7+061ZnNfWIM0l078O7ny5cxHLL6cL9QO4atLNr\/\/jj37cq2qXc2xbsfB2u74vjvWjj69+snjzXbEU3MNeXx519u\/jx+ycehGzk\/RPN8Pr3SWX4EGHvgVabhhlcVsDMmDYIQSTuhUew+ahoWCDybjH4UefgjiPgDyR+ATlR2nT4gqrsjiPvIxVh8UhpVmRIs23ogjNIXwQGOKZE0X4EjA5EhkkUbWouE9pnUYQnw8QsfAkVJOSSVqLFj2oFFMelBXkJhVCWaYYupxW5YMmjBilqyNyWabbl40AHUcxegcA1huWOKbeu7J5w3c8UenB3u5916fhh6KKAkzitTYB148aSZ4iU5KaaUBVBPkWQXodsGjcpaXp6Wijtpnkjhx6LjNjpnWRmqrrpZ6ZWkYTvAIK5G+imuub6apZD6KrBCSmsroSmyxYca5aj52HlaEpMY+C62Nf17oJV7ORotttiBOd5iZW2oLbrj3iRdct634+q246q6rnandTkIJu\/LOi+Ba5gpIEr367msfr73WyG\/AAmv3opIAD4xwwsk52BdJ6SoMccSEATnnwxJfjDFd9oTDYcYefzyZZn41CnLJJg9WU8oWn8xyyy6\/DHPMMs9Mc80234xzzjrvzHPPPv8MdNBCD0100UYfjXTSSi\/NdNNOPw111FJPTXXVVl+NddZab811114bGAEAOw==\" style=\"height=1303;width=1024\" \/><\/p>&#13;\n&#13;\n<p><strong>Molecular mass: 378.3<\/strong><\/p>&#13;\n&#13;\n<p><strong>Pharmacokinetics <\/strong><\/p>&#13;\n&#13;\n<p>The pharmacokinetic parameters of mefloquine used with artesunate for the treatment of uncomplicated malaria and for chemoprophylaxis in healthy subjects (3\u201323) are summarised in Table A5.10.<\/p>&#13;\n&#13;\n<p><strong>Table A5.10. Pharmacokinetic parameters of mefloquine in studies of currently recommended dosages when used for prophylaxis or treatment of acute malaria (range of mean or median values reported). <\/strong><\/p>&#13;\n&#13;\n<p><img alt=\"\" src=\"data:image\/gif;base64,R0lGODlhAAQvAbMAAGS6uf\/\/\/zUyN63a39Dr7ZigoCCAi+jPr3pjUrCNbfnoztKxkILGytDRz+\/6+\/346CH\/C1hNUCBEYXRhWE1QPD94cGFja2V0IGJlZ2luPSLvu78iIGlkPSJXNU0wTXBDZWhpSHpyZVN6TlRjemtjOWQiPz4gPHg6eG1wbWV0YSB4bWxuczp4PSJhZG9iZTpuczptZXRhLyIgeDp4bXB0az0iQWRvYmUgWE1QIENvcmUgNS42LWMxNDUgNzkuMTYzNDk5LCAyMDE4LzA4LzEzLTE2OjQwOjIyICAgICAgICAiPiA8cmRmOlJERiB4bWxuczpyZGY9Imh0dHA6Ly93d3cudzMub3JnLzE5OTkvMDIvMjItcmRmLXN5bnRheC1ucyMiPiA8cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0iIiB4bWxuczp4bXA9Imh0dHA6Ly9ucy5hZG9iZS5jb20veGFwLzEuMC8iIHhtbG5zOnhtcE1NPSJodHRwOi8vbnMuYWRvYmUuY29tL3hhcC8xLjAvbW0vIiB4bWxuczpzdFJlZj0iaHR0cDovL25zLmFkb2JlLmNvbS94YXAvMS4wL3NUeXBlL1Jlc291cmNlUmVmIyIgeG1wOkNyZWF0b3JUb29sPSJBZG9iZSBQaG90b3Nob3AgQ0MgMjAxOSAoV2luZG93cykiIHhtcE1NOkluc3RhbmNlSUQ9InhtcC5paWQ6QkVGMDZFQzRDNDFDMTFFOTg2ODBGNjdDNzEzMjA4REQiIHhtcE1NOkRvY3VtZW50SUQ9InhtcC5kaWQ6QkVGMDZFQzVDNDFDMTFFOTg2ODBGNjdDNzEzMjA4REQiPiA8eG1wTU06RGVyaXZlZEZyb20gc3RSZWY6aW5zdGFuY2VJRD0ieG1wLmlpZDpCRUYwNkVDMkM0MUMxMUU5ODY4MEY2N0M3MTMyMDhERCIgc3RSZWY6ZG9jdW1lbnRJRD0ieG1wLmRpZDpCRUYwNkVDM0M0MUMxMUU5ODY4MEY2N0M3MTMyMDhERCIvPiA8L3JkZjpEZXNjcmlwdGlvbj4gPC9yZGY6UkRGPiA8L3g6eG1wbWV0YT4gPD94cGFja2V0IGVuZD0iciI\/PgH\/\/v38+\/r5+Pf29fTz8vHw7+7t7Ovq6ejn5uXk4+Lh4N\/e3dzb2tnY19bV1NPS0dDPzs3My8rJyMfGxcTDwsHAv769vLu6ubi3trW0s7KxsK+urayrqqmop6alpKOioaCfnp2cm5qZmJeWlZSTkpGQj46NjIuKiYiHhoWEg4KBgH9+fXx7enl4d3Z1dHNycXBvbm1sa2ppaGdmZWRjYmFgX15dXFtaWVhXVlVUU1JRUE9OTUxLSklIR0ZFRENCQUA\/Pj08Ozo5ODc2NTQzMjEwLy4tLCsqKSgnJiUkIyIhIB8eHRwbGhkYFxYVFBMSERAPDg0MCwoJCAcGBQQDAgEAACH5BAAAAAAALAAAAAAABC8BAAT\/MMhJq7046827\/2AojmRpnmiqrmzrvnAsz3Rt33iu73zv\/8CgcEgsGo\/IpHLJbDqf0Kh0Sq1ar9isdsvter\/gsHhMLpvP6LTa4iC43\/C4fE6v2+\/4vH7P7\/v\/gIGCg4SFhoeIiYqLjI2Oj5CRkpOUlZaXmIIOGgMGDJ+goaKjpKWmp6ipqqusra6vsLGys7S1tqiet7q7vL2+v8DBwr0AAMPHyMnKy8zNsMYbAGvT1EzS1djZQgQM2t7fOdzR4OTlMdfm6eom4uvu7x3tGejw9fYT9Pf67vL7\/ub9LuT7R9DbwIIIqQVMyDDNwgoHG0okE3GixS8PL2rckhHfxo9f\/yqCHCmlI8mTTUwGEImyZRKWLmMSUSmz5g+VMG3q3JFzp08bNH8KlYFzqFGeR5PeCKq0aYmiTqO66Cl15iZ9TKtq1QD13QM3oghc3foSILdQYnc8GPCJwIkGnwa8UADAgAG397JSW6sKL9khXd01sEu4MICxf4lQPaOgsGMAfm00ttvNRAG7iz9cxoy18rrJjkN7SgzYM4bM1AaLJhz5yoMGiEeiJgN6tdwboE2P2Dybg2oDvRXqNld7NeUabpIQGBCb33CI9X4zJ9CgLubmUujabQ0yeJjcbQhs3o6b8HMQvF88YAAc+zq90x7ULWadMH0Dt2Oo9q7\/et7zHsHzm\/9f8hGWXxUDtsTfF6Dl98B4ALqQ2wnpHQWfNuO5B0OFRfCmIUARrhQdaxT85lkbA6TYmgMDpLVWZF+l2GIFy+EVY2TLMYcBiy2O9RV7drWoIwU5cldjADF++M2CXjRIwQH2IZniJl+lNcFaPVpwZAA8tjbhjVfK2FqRAXB4ZZGIoUmkihJgaWWbZIK4z3g4zhjAlnCyeUGMWUrQhnUA6PniVTX6qKcFN8aG5VVuTtAGbyoq6U1g6yQ4gYkBVFcfZn5tRh2JAxTzGKPWOVCdfQ5oZ2AFp9pXWXGrStAqZvlNBkCBo73DZBdOTgCaNFB6ouptqprnI2brGeZXg7NClin\/qr6aVyZnbTKwqX\/TUvvscdveVe1jDEjqUIjm0HllqUBes9amzlZ7ba4LrLaJagzgCpxbnUB7JZD2+RVsN\/y2F0C8onEnpwa7kmGprNL+FhpevBW2yXiPtWldwJS9O5bDhXUDa5BIUlwYsfZJq2s5vUrwawDBigoyx\/o+UPKoKs9smAMPksiwXRNrm7No6tbnFq6H7exttjSDc2E25lqMWZQ\/P9ymcd0QHNq8mF1rTGieFesYXvu9W\/VqBpdDqToLIy0XXYGmyG9lIgtcHQMyCo1kfW07Rje\/JNMaKmt8mTdlt20DusnHB6qT8BYpDyxtsF\/bu3eUSBqWYn2vWv73\/8smZ3uNmXPXrfNv0kh3KYky+20tuWosjU3Td3PtuN+GS1CAMTJKrMDmbevoMN3spqgvhMJT63DehOHMu4ziZnN2Opa+JvGeFY5XtHtOEn0VprEDZ7vOuFa28M\/ogOZWbXI50Dw2i2uRssNuke4W1iB\/T17qAgewsv76fgmo0\/ixn0hSRqf\/nY48jTvYPWAnOfXhjHL8I88FLGWmbvUtf1Y7X+d+Q79cdQti2KrH88xBOpfF6gLVS94GfiYXoh3waC504QQ2Iz6dRTCAAFxb5+rRvizU5j4mS5uHogUy\/JlmiBMCINxIZD4BagB\/tSpYiZg4svW1jnXkYKABa1a\/7v8ljohHq2D0aPjC+NkQNB1cls6GaI8RlgNmI6vAj4BHLTbKES6fWJUMPzhDzvyKLXTM1cIgFyhQrCqBJyPHx044vi1W7jhGpECGbuigi3FxNPvpo\/fuOLkudsuTfEQaZcqGDddVQ4va6tbe2HJCKXUyjKkM5c+6RiIIxYVfZpTgDUGYPxGGqIdggCPdEJMsoAlQUe8q4hYXlp5FBtGGcCyMBkGZSHB8LFCRaWQqY7hDqx2uc+HTpDQ2kx8zeU2aFChOa6L3ri86D4vgQOUmjUY2WSUTlvM0mo3IKAHIuSVujkkjGHlZtDb+ckS6RJT1PmFAO94QOHlUpraY6UdXjQL\/bDYkJCm+SU13APMKiJyiLvfYPWlEUpwc9WA49VkqcYIxF3bTJAT1WaJrkXIapqSGPOlBuo0SjqEq9ByrwMdPltXSPKSg6SUJasV3jkNANrQA5MpZxxDODobkLGkZXbpSDCysiRgI6To+agWxKvWYYOzGSUNGrSR2zzPhSyWH2Ig\/v5CulWlT2XjcWY2cTmOn6YwqBcgHxquIkajcMip5OJiBr67Rqu9wIznyKlIYNtSqbMzeMm2Ywl5aQJv55BIY+ao4lLXys1E1nQQy+EgPJtGtXb2qJytEWKUSDX8FDSVizIpTeH4DsFfaoWhb6xnGeg4xY0ysPylZgY2d8bGe\/43sQaGa0AoQkjp4Q6tMGfApPW5WlxX6oxs6QUtOzYh0LeIGDnlrDrJWgbdpwx9+lkM53AppejeEqyVfejT7zdcBe6WvzqwmF6sVd43YVG91naoP4MoUMsthz9Dq06KAGdZAyxEoWz243KhxdznF2N5zJWjgDMNDsuCgbHBDc1nPwtE6Lfxuf+dqHFLpbcMsviRp0+FeKsBXsNGEoXFwmN9zJda\/+bBakF6MwPrGNEGL7PEU\/LoGBwMwxwHAGHCCCrNcYlW5OnNmDXUJVljt+Bso\/oaKfbWpAaSuaJOs7L3opdWzgo7FQ\/rkJouprEv6VhtSzs5prSvYTGmNQKsJVP9gE7tWoyXOa3IJGGRU4+Y4E06g54yuNqisBitfuV\/fQlVWkYQxuSR3nstV2bvalepdTqDUJ56uV5i3wgYMLlMpkkCO3IklHTUK13aS0q3vdKg22XrYg6V1spXdJjHpI9BR6PVNe+2eXSvKPHFadrCB3Rr8Nec1kWq2ndwkbVbRmtpnYjY5OO0QdR+7bL3Os68EVWw1CTvP7w4TsvUnJmIyG90TsLYvn0qaghM8Jo1Gga3+wm6DDyXNDk8MtMuR8BKkyjo3TUrDI+4TiHN8KxMnR8VH8MPEbPzjNvE4yqUScnCMXASEbGrH\/7xyjcu65gZv+TfWU4wze4Dn4SLNyXH\/3hKVEz0pOj86Q4au9JEYvelCSTrUCcL0qWvk6VbXidSz3hmuVwXrXo\/J1sMea7I7BexmP8nY066OqrOd6hHqBH3mTve62\/3ueM+73vfO9777\/e+AD7zgB0\/4whv+8IjvO3ASz\/jGO\/7xkI+85CdP+cpb\/vKYz7zmN8\/5zt89Qg6AcCZGT\/rSm\/70phc96lfP+ta7\/vV3YNFhYE\/72tv+9pJg0c3fHnXeW4jmvt8I2oN\/kbUTf1LAP\/5Ehq\/8hhi\/+X1NPvQTwvzpF+T51r9i9mNS\/e3vA\/veN4Pbw7\/u3ZP\/I+A\/vxjGr\/5Nm7\/9Fkk\/\/L3A\/vkL5+D2n4j886+F\/\/rzf1z4938JsX8CaAX+V4Bl0H0IaBALuHTS14DIF4Da8AALkAAIIAACgAAF4HMucAAFkHEp8AAJ8IAKcIFlowAb2F7wUIIY2IIu2F+ZUgAXmIEF0BwKUIEYqIEgyAGvIYM5GHSs4oM0aDAJ4IItWACfZYE02AD\/sQ4iWIMZcABFOIQXgIIXqIFMWIU+iIUnsABG2IIIQEwNIIQIAIQqM4NfmIHrpIQ6mA4K2AUHgIYuiIQ48AAXyIFdKAAGYAIsWDYHoIcyRxErKIdgCIgT4IVfCIMs+IV4mAFTaIRQOAF\/mIjc8YgvWAGICIkGpQ4saADukYkumDhx+IXDMYpG+P+AoJiBF0iHh5iGnugrhJiDhtgmltiCDxgGb7gFk1iGYpEqC5CFN1CEUmaHAtCIVWiCjigABPgDy2gEDvSMIliMT6KDOIOIrIgkCIAAsOEAo\/iKJbAA1BiNAmAaJfiB1biKFlCE3fCMiDGJ5qgAU3iLZ3CAUpCJ3mhdGFiDD9CNBLKKYgGPGHggLPiB+jOFxsgGDjQws3iI4YiIpsGO6hONB2KN6gOQArCDAIgw1rSKgcgCCrCQMfCH90hyyBhWJbkkBCGSsREbXhiGg9WOAWkCDxAbRbiHFMCSGNga6pgBxHiNAVCTHZmRLjeFBQCSbYKOsDiOrTiSQDkBTUmLRkn\/Ah8pjXJEk1H5JAtJjKYRjT7pfhJIDU\/pAztJA0V4kBbQhxpQhF3JPgQxlhowldN2hy3ghSN5ljlZAW55lnKZTif5HvLoBTVJACopVXdJAXRJJReoG5NoI3spiYUpk2rpAYOZjKYxmY5Zlww2D9\/Agn95Ami5WlAohdkYiXdkgaMJG1U4iwugj+DIhfojg22YlDcFl+DQjEtAmxuAmxhAjGa5AYf5lo8pAXlZAbo5AY3pl+WwmptgmUsZG4vJMsGJjUoJnTCoP8dJAr\/ZAcxJnH2ZnVfSl16pkd7wnD9AlxRQhA1AiAjQGqZ4ihfgluhJiAMwiS64LOApR4lZm\/8Q\/5kcsJ3ceZEtwJ9RaJTDmU7R+ZPT6Rzr4J\/CiChyyaACQIfeeZQJKpXXqQFeuJat6JPbSYwYOY\/vNw0TygN5+YgF0AANYI1YmYEomqL5yZ399YgMgKJXqIcoCo4RKpsbIKCA5g8e2gENiqFXWQK8uaPKmI6qGJvfWaHCyaRu2JlgAKHDoZUKiZn8OaIIyh9q+aEvuifXOZWJ86NKE6JrEJY8UKROGZNp6o09iRgF6oX0MIX+goH3mJ2fmQFYSg22mQTmyQF3igEFegL+OVgXWotMSpEqY5Blpw4d2qVLWjU5agEZ2qRrGaTY6YII4HMfiZmX2RxFmKm+Iqfl95Vlqv+HQCCmlIqPR1OcCKobqJqlhFqhm4oXf3oBIvmhgqgPaOqbkTqgnGoCgWqYUfkaBHCDM3gg4piNctib2seoRkmlSNoNPLqUqYqkNomdymqLRloR0PqfSdqCv3p\/4qkNZroDm+qmR2qgRzOiw\/mHPpmXu2qdACqvGVer1bCnRzCo\/zltgeqBBfCvABuwGqKvZ0iVT2SmFIiGJ3qfCmQOjeqkVIqlk4qglZqurxmwGEuaVSiqGHCrvuoeD6KweRp9pKoGLRmUKsCcllqweMGuFRqvrRqrAlmS9oqfBpsN+GoEwYqXFosBeZqKRvirMIukGmqX8zpYCpAWIjlwzmqlPUv\/oQUWlVcqtRZLn2koAErSk7vpqEjKEg+QtJsAp2ZDpmpAnj2gsk\/7mS5bmQT6ssf5mTUrsyh5D6x6ASNbsHyFghkLsMBItBtAsDa7Y92qoE3rqU8rnXIBoRIalV16g3v7r6hppBp6t3HrpTcbgeOaDZz5A2ibD2rbtqZRltEqtzpKryt0oXqqDxMLnJdrs1C6WkOKtx8wtMJ6tISbDv45orTJqtBqtlDLAquLldWJib0KpLErrpr5DRzLA8W5sqYLnbYbsypDtVv5tjTLsHwZvfd6D7QbqyGiliirl63rvSDwhy7ZsRj4umNAj1Pgn2BKvK84uPpTmPLruygwrfIq\/7io67NqOqqZq7kXOLzhO7t96bxw66ib26TPAa\/WO6+V20\/HmwY5OwR3iyT4C78DnL1ndsE8ycEKGaEZLH7qC4fDGsBjkcBVGhk8GphX4sEjMIlhyrWEGa6DpaINKxDkkInm+BoJoLExEK8GfJJEqT6m+CoMy8A3e8DFOJMQ2alzWw8yzLMfyMQJuZQEQMXqI5OJiTPPKMVXzI7ptMPpeaDGSqchLMLmwMR0+cUwGaFXPMb32InMYZGR0YmwQcclgILbiIL5KEfgi8VWSS5WmI9n3AW5qIuxGMErsLJBfLTEiKkvKrbv2bPxipuL6Ip44cJqMMFBALhTGIuesYuJSP+kMxiL+YGIoHyeXwiqNkvIXSdyiXyolGhdpixVtfyNaaixycqIwluvYMisaPy\/3kCBpjmauCqoCzmcJQiDCWvMXqhW2AuvFjiz61mwynrNaoi4+lkPOyuvV3jNZQiV35ytRduf4AzOtFqj4Fyhonma7mGBDXDMmOty45ytw9EAxezDeqWsBKmF\/CzPxAmbxmzL56ysE1m8W3uihYwRZKsT3SsCO+muPAC4mwyBCMG+Fm3IDW0OC8AArTkAA4kXcTiay8nKypmWhzsCVCq6O9DNa8DJGW0EGB3T\/bfR5fCpW\/ivkWqBBTCWCeCJJRgiD+xVBCKnFA0D50oOME3TpcH\/1K+cvPfw08uZrlKNlzZZjhpovOVsudmavkiyAMB8Aiy9zU69iWXNtFBtD1Ud1MIZvxVogehw1No8u0r4y0AQvE981tKl14ua1tz8imz9k55IjNnYq3L9mjKHxUKAggCdq3x9u4\/9pCWbDmsdzoLtAF6YydcQ1D89fUsd2Tow06D9BIdsBpVdGVLtrvico3aIhB85whH32aO9FLA921hQ2mVw2qv1ita4mgNTzb\/d2Eon27ZNA6Jd3EqA2+nwAM0FfcSN3DFw3NB9BMo93VTw3NbdAtKd3U2dAQSQC84Q3uI93uRd3uYtCuB93uq93uzd3u6dCsXw3vI93\/Rd38oA\/w3e3Tsyst\/83d\/+\/d8AHuACPuAEXuAGfuAInuAKvuAM3uAO\/uAQLuD6HeEUXuEWfuEYnuEavuEcTuHWsmsdHuIiPuIkXuImfuIG\/gmTzd1lgN0sngLb\/eI3YdMyDgYuXuNPUds4ntw0vuNccOM+HgIxHuQ4UN1EfgRAfuTxoONK3t1+3eQhAeXry+RSPuMrXuVVkORYriVUvuU7YORe3gNaHua61uVkTttXfuZOMOZkPuRqDuM9\/uZKwOZh7uZyzg5xfudIrucGaOZ8\/gJgvhfFXNDKutAr1M\/TzJMLINz3QOdJ8IRZO+gGTaSSrqwAUoJhjdYncdJ2W9D6LJmETv\/S6VSBp4kSgR4fsWyEjA7RkRrFEEzDztcSFSydXxgcj1yI48sy+7t8fq4NiFg2QKvI6Hu1xRvsW90Qpz4NCtCiDTCK3MXsODCZ3azJDOHo+WrGp1uMzB65UrntFyyOuc7rJ7GIwC2pbszswv0a246iY62QJ8ruXu10ef4Pr1qHjdnNDx3rJPHIsF7vwBuVndjuwtfr1DCKPgjsTtoCSztYOinsBZHs2ZDvMmCZLo3XxXcSaokA\/Y69CnehBu8AAn91BL8GDhm3Fs8CEq+Q5\/sREI8NKQ8D7R7RAPtoHF\/tJEGXDRDB\/q4CFxzYIX8Rdh4Gcbg22HvyK3DUhw13aY7\/EC8vIRiIrgxQixrr0ghh7UPAgiCt8zVfAkf98xYR9LRR9Am\/yGMPvyTR8tXQ9ApvqqqcjwWAoxXapxth9UFApUn9RFfYw33rmbuuypne1yRh8jSo0C0w1Ap89vPuo30fA8MZjy1cvEn\/fSDBn3fPk+q56k2ag5+epn+\/1ygh+O65AkZPnAcK9Im\/D2rPAtc5rd5p+ARB9+U5i5XfWC06hbDOg4QYrl4v7p+PvcuOokLY+XMtuSeB9nux+Oqx+kxqman\/bBtRguU++9rJtSm6ANZ\/\/dbfz2xQkH0MqOEuEWA\/Bq4fjSN5g9h\/\/tyuqpJStyK\/9AXR\/CmA9TyrmFmJ\/\/yvrxGEvc6qqP0cAAFLGBdsQEJvXu4HJYEAr0QYSnVlW\/eFY3l2CYbGc33ncSUjwX6jz4Fz1FRUp5vrwexFpVMqy+YCVLVbruyRSXVZw7BJ0LwYKZcvSvyGU7Nxel0mQh6DMLXSsigIFBwsY2kr\/DhBtGNsVLlyjJQEGdpzAvtQSBjkLPArmvhckVibNHWEZJk7ZY07dCQDgQItDXhtxdVazeXdeWgADm4gDRZt6au6LVHsbZZKdY7eqYxR3jnZXTEiku7OgVbJ9h43xGy0DphNC2UzJ3\/\/EIeft1BgpyE15qFecqP\/B\/dvHr8XbSzlILiiDRqBABmGa0gPHZ2Fsv\/OgEBWD0jEcfI4drNXK8aQh1FOiEzk76O3gCulJWyRr4cEDy2eCKjp8l3LeDq9TaSjzoLQABmL3vPJy2PSXCE\/PQjkp8GeAxlQ0gCmRJOGRWa6MmXFE2wrmBZ+aT2hUgfQlJ7GdhNrYelbSWzhkLL40ChNuq3m9o3kNOVFWxkQHNaA4CCOtIg1lJTgWMBhBPoA14l7uc4Jx4hzBhAhuSQOo\/0QJKBM+atmzKN7sjZl9409bkMJr6tFFHadv7vjCL4gIsyTDIndziw+ucBi0HmS+LaTGTqXtEgMFEmOYLkU3aCcq50eJ3Pv8FseWHaVgeF5Y+cvlC3PhXx8Le5B2Gf\/40B\/ff3oH7Dvrz\/63pBuwCgADHA\/EAKkAj+FEkzQQDjGk3ASqAhYQDsHqkJguAw1tCWBJqBarbmrXOCrQvlUZLFFMQp0MUYZW6BwxvQomwzHFDg8bA0JUkANvQBi8cIdG3eY70glZYRxSSdVrPHJ+hBYg5kvPLDPiCASMKCqEv+YYIYUpaQhSTLPDK9JNNeELUo2efiiiQwruNIsQE4IgiQYbnKthNLeVAVQQelTc1BDdXLz0CLlVKwwDzLcwIAgZMukgC\/fs1TRFczUtFOBCvU0VHISFVUhBBgl4QsAvriuqEZB0+7VUsXgdFZbmwH1Vl3D6lOuXVWI849GVcVA\/9IGqCTBS1aF\/BWHWpuFtpFco6V2wl4DePbQYGFNVTtXlVOM2CFvq1aHbMtFV4tp02U3ClKbVUCJB\/aI1ywC6HRgXj8UYK5dLPwFOLprAya4h3cLRjiKcxNmuIR1G4Y4gLgIAGAAiy\/GOGONN+a4Y48\/BjlkkUcmuWSTT0Y5ZZVXZrnljyt2OWaZZ6a5ZptvxjlnmhmAWWeffwY6aKGHJrpkBnolwICjl2a6aaefhjpqqaemumqrr8Y6a6235rprr78GO2yqARC7bLPPRjtttddmu+20AajYbbnnprtuu+\/GW2uy\/424b2f9BlyGhwMn+GDCD8cWccVBGHzxdA13vP\/vhSN\/fGDKEYb8coYn15zaxjtvNnPQCeZ89F8\/N\/1W0VNvt3TWbUX9dVFXl71c12sPNXbcNaV9d2hv911R3YMftHfidQX+eEGHV55N45svNXno12R+ejKfr+KATgYpQkRKMpUCEGa3AKTf+rbffnwegGlBk+N+a8AvNBXYTgb6A2lAFKjQv\/SOz\/wURP5ooD31sah60LlfAQRov\/pVYQF9AkQnvvSLQZjvSdijAh6s4we8tEMDFozBNqTXPqsUEE7J+Y4ATOgDKqFnGyv0hZEkMcLLVAU8hqhOYixBmzz0ryAn0YcNOSCrF8hESgeEzU2G6EMbgpAGN\/mfB5EwF0j\/HcFyNsLgFIixAC52MX7BCdMHjLgP9XSBfgepCB2GwcVhaECBXoThDLqzjsrU4U+OoGFf8ODDtLyxOHv4hRcbcIIoIqQ4VxmCdoZhGCcq8URYvKKM+rjIDxZxA060X3EKWRicrJGLFoyMH7nypiyGL4wxOeUF4tiCVe5pIyVoZRTgw4U7gqKOmxFAHmOgS7DcBDH92wa9MrDJozxyBjYsAFLMUIs2ENMCyGzh9SLpItqUIY0r2ApiMAkDESRzkwaZgQIWyMlWUe9avERlOVnQwX+AsymvhAOljHBLOtBmm11Ap0+GIClmXCKXIZgAc4jEAxEw4E8DfWZA1\/mYWkKS\/01qAOhSkEkAePoiLQMY030qmoMxnqmUUWDnQtU5JAUWIQwKAMQ4h1FSEDSggQ9YQBBcqkB9BDIQgKRkAVJ6AZcuhoI09dMXxXnTcG60C3f8aQNK8wCU4u8DMG0gpr44pAiOMx3kwqOTqoIlGaoAJgg1gzNlgJpkKbOYaOyqCTpUzFiWB4magagY\/6mNU3HynuVoVEafatQBmvWI55xESEeRShP5oYU5pMAQNvA+ZRgBAIrVYSZQcwS38JADpSgjdob4kBZqECeZrM0bdFPFIcprsh2Y1DBLkNkcPgaMxoxDPn3yALOkFSNmvSZu7moIJfxJDWi9YX4SCtsYvfUy9v9MSYnkxVcc2EevHtxtCQQrTb5FYrrSJWxGOaOcPg6zAMVBQ2NzhJMCpKUW29BOeTWQBaj0MRBoEEpoAgHelBhmvqMUAnOTIcPGBKIxWjGOej8LJkllYiPone9a61HJGZ6JUoVdxoA96MNjmhWsD2YrddnEmSB0tByhNeU3vTsVHczRSR+dSUAJsGIWf0Kw2nUtmCazByDWViXopQp+bRFTuZbCnSlBwxDelxYau9GDYn2PfqkAnISSKyMwnepRuIFQZBDyqXsNLm8cbFu5vi+sFjkMS6fwpzYUOA1cpkVb0zRNFykxEDgp4I+1KGGNUhaGszwxYCXhWQ5Y4sV0tvL\/e2I83OXeWMec7NWTjaqOjrZhFYF+rfrwTIXSQDqh9CwBQSw9C2y0wMSx3XKW26KCkELWjWrGjTGEKIjkYLKhMzIua3J4TzmHeJ2s1gBxAYrkI6GYoIlJzWH8nF1Ak8sav7VxGZAN5Pbdo9ZXhe9ce2wGvfjVq0qe82fQMU\/\/wDOYNu7wYywjAdlChEwPfq6JGLfiYw3aLMKAN4m1YW0hLlbYfLC2Q9kExSr68NnvjncwzJduUrvbBWD1qJ6tS9iCjxTG6zFSSFJraDObIRtD9e9kCr0YdYz2HkRZ9sGxzR1pD2mj3H7qTAUMyMzGNUTGWcx1tXxuNBPYGJaOsEi2\/\/Edy7xa5RvK92113aJY9wWKZrmoK0EMxu88kuD9GPpVy90XX+9A5tPuMrMnnAmFclLZXbc4G1qbmI1HGA2ZtaUSQA52Ei59C50WNIhRvmPnDLtKWCXt\/64OapqLOtIRdiZyzxzs1Hg5zTH49OH\/yqaO1tif\/eIR4UFUcF4TGt9R13eg9sxw7Dq82BBXi8STrVuLPNqNOgWEsxd9G4+XYu0Vb3t0GVNywdNR7cbhYjJDS4Z\/D9Lde4fD1GdbcykDt1cYfsGrvbNN5ReXzSySoegfr4Wn+ynoSfb7BRXuCOCrO+vUxnIhpC9e2Et9wWpR9NI7zvCTgJ8WmJx0tsMvdP86ob0wKMEGkzvPQTo3Qvg6eTCwQjiuczvSuD6N6L9jOEAXKbq3QIf4syvqS0CRYhY+MZSq04Hu+7PPEAprGD93CDnbmIMXooWty4t1CK1rej34GzmQSqWjq68KSAj9KyYJSDSkgLtI+D+XwDDHs7l0QrUMa7vyU0DMq5AGfAv7E0KbaEExmUBgUcJ+MDzn2b5G0EBlerj5EzQzI7+DgDvaQAMb8rHMuhfbCC+rmJSTKLJqI8JrK8DswcJBC436kzAbwjROqqgHMq3Pm4QddIm0Eqccg7MmYwh+YQPhGLOgQ6nIaimrSjUNQxNEfCbV4ilHjEAHekL82ArYy4ouC8L\/I6xCRggNwnsf9PKW5uBAY4u4ruvC0jODHDGMaLKN8QoDodg5HFGLFcyvAoSprjiABoCpMLOg2uMkWMyRUhjFWFw6EVCnNkgNHfu3mVsSHgG2ydsn\/jPG\/uMMXHy++0CNzjgM8asOImqyVSAOcFQwJUHCsWiDbDyv9QoOXKSMKbSfb4zFcBS7bFSLggKjWAk22QPF6uK+pvMDJRqwMbK\/Y2Mw8QKxHDRIb8ET7EuMMFDCepsMRFi7NyRAgcrBRCiAHzgNZPmwh9CE5PAECZiUvHOAH8m0ikShdFzCrHKSsdsArSghMcoOLyOOJZIlFOIA0INJ7zBHn1ysPHsTqMjJ\/08QoVfcoGn4DmvKIe04iG1ogp3rISoUyHMIOGBYjECUF3mrB0fsRDYYywAoy1+IsrA8CHFaIHF6Cq7cF0scEq70KkdEy2ooyzP7LnH4ARIAsF5JN7acFKtCy8FsD74STMAzBT9sCLYMuEywRLSUS1sQOCrYSkc0xPaxqssEyOlYR7qQTH1wy\/fYys6kzK0UBce0DHEiy8v8xDXLSuthTQQQh03QqF4hxi1wuWpoQnyyHnT5zN80oFD8TXFJMkToSxdIvBPKPuyqPFoRzmoJzuiUEAzsHOP8g5FKByTLTSlASs5jQo2kA8akTkLpxvIkJeK0Huz8AuQMysEyQnybMf8aWE6+Q89dmc77dCv1nB7snJO9iqRNeM16KJ8nElBWIE\/9hI78VNAF5U\/oMc5tMQF6lJIEbdA2Oc8L1b7YLE7aPDMXa5QBnQ4L1dDLYNAS1QzrpBxT8wDvYbqiXBMSRVG6ONEZpboHPR7J5MqqsIR4M80BkVEbBYsaFdKxUFHTAQRRCdIi9QkiZdKkiAsHAAAWo9IqtdIrxdIs1dIt5dIu9dIvBdMwFdMxDdMGGAAyRdM0VdM1JdMpZdM3hdM4ldM5pdM6tdM7xdMqHQA3zdM+9dM\/BdRAFdRBDdMB6JUBMAC4UdRFZdRGddRHhdRIldRJpdRKtdRLxdRM1VRLPZr\/TfXUTwXVUN3URBXVUjXVU0XVVFXVVWXVVnXVReUZsnnVWaXVWrXVW8XVXMVUnsHRJ61QX73ADAVWKOnVYVWSJTXWhnDSZI2II2VW30DWZ52HZZVWenDWatWMaMXWcaDWbR2VYvXWCtHWcI2GbiVXabjWcwWLcVVXXjDXdu2FdIVXnWDXeeUVe2VAcMVXaN1XohPWfh1SfQXYbB3YgCzYAZHXg52HelXY1mjY+EhYFmAfYCnQTFuAyYQq\/BHRU8hMOOhYHaCftMwBqNpYQ\/jRv3EwsKSECBoEBlihXzhZPxmAmpqpu2oqlV2Sd32H0QQWlburjI3ZEpjYD1A5TpjM\/xUY2pwV2ClYFigMrjsqySMgx4hoWjjopwwEz3BisN+QRWl8kgGUMiTYpqj9V+u7CtKaTydoLQp1vjOpiqvYyQ4Yn2AcoqD9FvxzjqgTw5Kl0aWVgm3oCqD4EzxIr++6w4iozx6AwHSSpa2NA5wLPjIRoq+Yp05QHyF6T+ZECfn6rrRVCPcyL7410rL1DZjKNWOgjfTSpBfor9A9kOowPO3hhBY0SLbNVw61WngsAcFVpm2IqgAQ3UZoPlOanO57ge4UA+STAoZthtDIMiN4TrmaDJE1idM1sNvQk4WqDao0SifJpq4Vo0IQgWHUMRv6V8Vy2R\/CKlM5NUjclEb4Af8DAN\/RM9uCHKbgjQ3iO5DehM\/GFU8JjE8k8V7D8D3KzVoW4F7yOUalJDZiyq2rCmDYnMZhOpahkw296sjmUsMY8LAV2OCEw10xoImrNUH6Yzq7bYYnw1nKZA7JLMPBqomzCMvNzEvv8wGu7E7VJNrIBEsd\/QSw3QLmzQXozRfb2k2li17QqmAG9jyJctziU9qZvIjh9TpUygZy+7WpnbfmbI7\/ZRK\/ZU6MSkDeHcMn1AlGMyvBitoNmDwttIdVGccbqDeYNF6MiMqtDcbsGBFKHLVvYWOGyGDodBIBYosjtqQI9icG0D9iJGGAQgnlNU8nmRfLKwg0qzQuZl8KC2T\/pyXd\/QxhLnAKmCBjm8RkgfgxDwspzMXFxXA5e0AMXNQ9x6i4OkZBfRTEZySM8Z2\/RMIRhujgFek7AzYAuqzkUpajz6LBD341yH3gL3bbBRyXNjyy3oJm+Cwgmrjcam7bFpi6FCGKUUZACvuHvUjjU2omQeQ4lVCskzqk3nIHWja5QWwyerGUPVyD3BKMMaqXuENhzZOSQpbaL+mDA0ANMeMBZKBBZyyAt7UgyIW2KJZcaK4+BDyVXx4rFKCf0\/hd7FMk1j0DpNyEfjZRMF4Lc2i0tMqIb3uLjELlU+qo3GQyhCIyrbNhblIm5H1ECOa\/msDiDxNnAQ5mbMJlvxth\/6k1TSKhwZe7JOWcwE2+3YjWNQxrR88d2WFCgtFY227DCSRI4kjmZjvICIQCZyheaTpr6XLK4NwUCmJsPGmDZ6LAaUquJq+QsRJJ3B4Q4mbAsGtkAdgFhs5FCQiJkBJO6lBiRA9u6pKDtU72jeGt48hojMUQbAaJu+mlpBsKhgVwXTe0bM02uMX+ZC0QCksbayBeiY48a\/rl570SCWIsjZ6uaX9Czid2AJS6WB\/8QllUIqmUwvEMNR8C4g+eRCdLIXoipDVyKTe62Ntbg2wyH4e+a6+WkuZbXEKSQTT0DuegpwReJiGRxEwzOB\/MvPetp3vEEWZC6XvI3rFAbYbroP8HdFzYPj9LuORVoGX4rg26PYJ39BE60+8EdOgg\/u2L7hPdsDSrRIJbQvC6W0IY7O06Y2zA0NlxaD6ndmT7pbMFL62cXm0cesKD0l8DidgXvUrVVrxmoov23twwwm+WAzHXVqYcvO\/o29r+ui\/0doNGtgUheogA14UBRzzFTq79I41N4AT3cgu4Zrse058QR9gIhw3ls2gQkCEqNtuWzL4AJzMnl27yjgMKhjdIa2YIq+u3aO87ZCclrD3oBe\/Qqu\/XKhKsEjww9INLLoCqbbhPiG6g\/mcnNzGP6+oxQIoHZC6VRkGRfosJ94ZXM\/TwXMv5HQkLw7YAp43U5HKIJWn\/Gkjq2hNvEbxeRPYGlnbcMuvu5buAroJxkZDxA1ZM6Q2CuRsuSpiABhDyjaTpN8jrXkA+PDvp9XVKkajIfHM0iwB131D0bmgo09ZCDp8BdJjyeP6KbVtyZ\/7qOEi3a+omF3vi0IgymEJ0UUSKbsrHU+LufXp1zkt1PXdrM343JeBHBOQGwMU+7SQk9JvZvzNxQSYT2\/rhm2x37HsfXZ4C\/YsMYaKzj\/1ueYdoKUlqRNNMP+AwgL8GzxWyp+p3pED4i5T4hffy5LWtMbLxzvV1wsW1MHSqgtjo+wggFyAgA6wFku\/c7\/IxGz+kLQmudE8J+1aO7UmBMqND8moMbmjH\/4zzdxTE8fRKi0LUON\/WKlwbhH0pXPOyBOHmXPpaMmUa+vuSFRsaytProw11kghCcqgkL04IMj5WLP8q+ubSJAHTuag\/bK6Xooybdmr3ZzFIdmhE28noEw4xajBBjIExguO7x4bmhhcu5jKgCRS6gYish6hsNxJoeLaO8XX\/jizg6yGJSgypDRZ1gI1CcZykrF3z2iOhyecYbrnFMjd\/SSinwa2oW6F8qqi0XX+VZKI0slnMg3KijVowNZz4UdhfrIPgs6haynEffrC\/ezMyaKH93Z8CqoOrKmFqAsc3hKM9iiBQEGz6Ih69aJ1flZTKkwVITY2lBhtUiOXOhIvFCP8xS6DtefXfvR8BQqmDqNlnMjygmKkV1nEICHLSai8FePPuPxiKlFKYp9k406M06WopS2M9b6GO37MMcWVmIlwOBeBEqNsxm87nh8CAUqtWEA6VmmS1hQHFSAwucuOqsHAO4pYVI1KSXl\/rdqu0o7nzoQtEjALCFMfNyk1Ag6JcAoKi4ooCkeKZZIBCggCDSkNlzZuAQcxCaJNCKMEDggBdnyvHqeiIIOtrhi1uru4ub69vXd6v8DBxsfGxR\/DGHrJrggELAjPGKdgBwqqAZkCmtvfUX\/Y2t2i3NgFCgYTq9PoqWACp7E6mKGl7c1Umvsf9Ln++gAIHEiwoQZnBhAr\/FzLsg\/ACwIYgnkWLKEeANVQPGq1oREQQOAFHVMlaULJWvFrVioRaIS\/OBUE5GizoNsWjRBA36rXqQKtnH4s5hxItqvCh0aRKlxpDWkEoU3IVL2GrOuhiRnjXiPyJdJXUmD9cT44BGW+ehUzqXvbz5lbduqhBvMELsXGcLqhy9\/Ltu8Op38CCB1sAPEHvUo7uNGCyevUSxgAHUF4D05VqyLAIxrpESc5BArgXVB25JrpQFzWEL5moG0JmL8SrZ9Mmarg27twMbweQnVSsHASuY0aerFV4PECYU2rmzHzCZAbINziAqRvXA+uvfF\/v7l0Y7+\/ix+\/izb0o7M8+i0eW\/4z8slmwEoCb7Jzq0Crl5HOf3+\/\/vxPhATgggSOYRxsp2kwHC3taRabYKZnNV8szkSgIjz8FEtafhh12KKCHIXp4IG1GqObBA6qVUJZqcASQ4kdHyCGji5LlEEh7IvLFoY49igeij0GOR6KQdlxW5FI8IrnkYEAy+SRh5lU3JZVVWnkllllquSWXXXr5JZhY3jVFmGWaeSaaaaq55poAsPkmnHHKOSedddp5J55VBjAAmXn6+SeggQo6KKFg7kkIBgMYAACjjTr6KKSRSjoppZVaeimmmWoqKQKLbvopqKGKOiqppZrqqampqroqq626+iqsscr6KKqz2norrrnquv8rr5siioGSUArLVLDDGluUk8cqmxSRyzobWLHPSjtQstNaW1Cz12pLVLTbeutLtd+KC96vEI17bkLdoruuHeGy+y4f2cI7ry\/q0nuvCO7iu+9f5VpgL78BmyswwXfoWzDCFcibMMMjANzwvgdDXPDCE1sM7MUZdyCxxvhW3HHGD4OMLscjw\/uxyRCLnPK3JbNMsr9P0eYCJRTcABQLSNwAiQdAuIAzBtm92ElDLmhn19FRrVzUzm588EjS6zjNwdRONB21zVDDorUNj3hd9XUuM3W1CGSjhvU6QJfNtQiWVND014\/49MmQMd8yWA\/iKBhWKRz8cZw3m8GSzoTQiOD\/0WRoJbSK3SCYtqF\/fwQuYwfXTH70Tx3kjZfVkivYOAWeC5AOTI0F7u9kbnmjNm1iKyU66SjC3njmPjXiWRObfy4CKadJkLrq3igeRKdor4byUrSMbhVK8hSyykf5VXW0Ku313nZLiRtvTCage0DLcDvul2BV2lCOAfnYaDP87\/kBbfno3qPYTfkidZB+NudTpaD69ofBf1X05x3XGQV\/5kvaXZaXvyK4737ZENwT6Nc\/3wWtGxQUhGPKR8FotIQ8yEsKLYQDhAecwXkbuJ5kOhgAoKEwJRvcQPdSyD6CxPAJ2hPM0iSSOkQliHaroJzl8JE+nKVuENs7oTbgkcDw\/0FHGzx0IgV4MoEEuWYyL6zbeHY4RSgisT1LrMAQOWBBsPEuievoBhNJkB\/\/oQh6XZyhbj5oFCki0XCjeceErqhGz7Twe8WT4RGJUcMIck5841FLBeqhHUWGToX7M0AD3BiTHwYyaIxLJBst8ENMziN1dEBkE\/X4HQISBZQTYOQdOVc90WBidJHEHRi5CIXqlcuUF0hQAfroNwFEZDLYgGNu5EiU1KVxi3a0wA3vcoTq7PI0utzlHpI5pR1kJ2nTtEEMqgnDQgoNm8wEBTCVkkOGgA8UObIZHvdYl945AIM9WWUlMeDJWM7wFLCcZ0qGd8PfZfI\/pMxJOf93zv8Nj\/8tLmynJGUgSyjg05hAKeczU5lGWhTgj1jkwDiHgco6bhMM5nBLGqvnmoimcgza81zsNrARcDxQgMkJnGvYkcArDlKZSDjAR9NxBpFCK4uOdEch+QlLWiZBB+5kSThHYMI99sSgHMRQ35gaygL9U4c\/fdElbxnVJJxDDkZNKCZFWcZjBmegFCCaCz\/gVEwCIBbx7Iswc0LU+22VBB1MkIJG99CfkhSZbPTlA71hEZLQT3hIMIc4EEWSNTZukPJYA2ITG8V+yiWjClmrBPaBVJjYMgnY6ElWrdBZrJo1n3GYK2ardwbtEeCtgqlqQzDLDV5iQLNvS6dUFQpLQlKQp23\/EetcLfASt3rQe5b1RUB3SdZTcm60wqVtI8VK2tV6Q0YJpF7+DtHDLYrwRQkaQ\/Wmc7QaJjclIglEaE3rl+MaJKK2pSdn6xocCNpVFCUYAhQGycGYOde29ixXQ4E3uhMVVzzuhW5aghpcz+42JRpog2tn29v0IlGs+wTnR67anbhKpLzoky9VDABZyia4XH0lqEB\/Zc9irpKT+BloVhe8zSm0mMG15FziWMetQ5L4vY1kn2yPGssCfPS8uaNwZoMq4Qu814IEIMAL1geEa9SPvj+SH2H6i2B0KhnJtQur3h7DBP0yF8snTjI\/Akrciy7DLx7W6nIdHFbN4TaPH8hE\/xV\/6luJmjPDBYXunsW4jbVeOMkqrnNlebxBHxsTJkH+bIIVZAILxlPGaGZyjxGcQLesYoabS2rrsDwYLfPD0gHwMliBaj4TZEPUt1Uyoz8syi9PFlFrvrIe3IxoONsg1c7l8nDODBnFFfrUSgbqcOxJhCI6Rht7CPSMVwxfTP4K2kpTNKb5IdulqtHKSV5QCnGcQccAgcyk5W+m29GARqSDJiRuYmnj6OrAHBgg5rY0rcuqODq6Z9zTK\/MFkKxVUUa0d16TByUivBQON8TU9PQrPn791CF7gMzFNvfE7VoLvAZvHNbGdDbCN1r9fjxJ45FtrAGZ4A0KudYrF2jHtf9RbsqaOqICn2wxJXDzYM7bLyjf8mTxYe18748OyRVwx2c+4WNTXKW7RnrMdfxa4wZG4sZ8tcjfnfEtztqiTRwexpE9l41r5Mlmb63YK748vTbd5VvfC3sLklqB5\/jlMoA0JsO3Vkmc\/exI4Hbapw1sDvgyamHnuXiK7fBYv5notwaqivvu9x\/3Ot5thzNMqJxB\/hE4bFT3eVeVC874ihLaZ84QQeNweGjfsNhYv7Mmqqc4zJJ818Qaj7KJV1oPm7rlAL+8CIrdUIEaPdVcFuvhcQNbcoaewWnE7PDL2op8O7xyV42+rAXt6scP8PN9kX3SAI9nTJce0SdWrV\/BznT\/aIPyzYNX+xQoSnwuV9v2JhdPjRtd235inyreVm\/QmQKFbRSXtYNsnREq+ITxeR7+bVLqUcMAghjRyZj7+VEhHeBzXVHdgQD3bZj39UWCiFgFoJVTdeCSdQCZnZgVbRa1Od05URFzKY7bkFbO\/Z4WAZUzLZQgiGBfxJ3cmVFZ\/cpNASFpvdAOls5CwWAT8BsxUcDfESEt2A381OBdgNpsLB9DKOH+VNthJaBQMREGWQcp0FcVvhUTEuGLaAcpNBbQrYcVHs8HgmB1KUJNjEPq5FINhJ3VTYgBhgJNLAAgBiIR2N7FrV9+5EAdZlIIIWIBqFDJteCE8JH5KII5\/Irr\/93eeFSPSLxAp2WTWszcJkoOD3IBIk4iDTTSJq6b+TzBIkYZG0UhB21iRV1VCTxQ+GDCTMzi\/3lgJuYPJzpScrViI\/bTC7hbKNINaYViyDmBMB5QE5EhTagiIjoN0THIG0ZJHPYF\/HCaEomDAVTjCRIeX8Wcs10iZu2cJqqOAG1jdaGX5VFAaFUheBUZkXEO6hkS7hXZKNoTWmza3mhSzJEVxzmjDemNkQnVMSmPYfkVQZoTp0ndFfZcYLSSW4yieU0DOx7kBBik8ARBkYEbE2Sk\/tgEvHWca9TDLGgYA2LUbHSB06TIENzjGyRADdJgGHgBCgzA+MVEaMRBGbAY4\/+gAFA8gImYgc2Eho79JAmEhmvc1xfMlmLZ3\/3tRxYg4+88ZRCcANiUAU76Sw+cAERqTlG2Qhm0QlFaJQvciEp1QVhGpH9UpQ2U5dtkQVPhZAHEjFOS0QgQJVjKQE8mgV12nlK2jQkoXFQwHGGgHxXsYX0Z5ustxCBdIia+TMZgIWU+C2IOxgpWwQbC3x08Yj4kV\/KJ02VWpkSW5rtkpmDspD4wHTpZpBWApjDA5COIIo5c41D4IGpCiWXuprGoZmAYwhWAYxC0pU5I5TDYk+pMh2ySpm82TG8+J29mo7Js5mw2Qk36wk5YBQNMmdZdm3QmTHSG55IAZ4\/oZYgogGP\/GoRukmeQjKd7Col5xqe1tCd9igh83qeOzKd+Oot99qeG5CeAfgh1Dii6\/KeBAoiAJuiA8CeDQgmCPmiBSSjM5BqFHuiFVmiGisttKEqvfCiIhqiIjiiJRkqtlCiKpqiKriiLWsqJtiiMxqiMzuisGFeh3CiO5qiO7iiPXomb9CiQBqmQDimRdsmhBECRJqmSLimT\/smRsuSGikuERqm8Uam3OKiV6siUZmmocem1YKmXdsiWhmmTnCaZ7meBnqmwjKmawpWZtimBWiicHgubzulhvqmdNmia5qmQ1CmfMgue\/ul+gKmgeoefFupQLCii3qmcLmqfOiqSKCqkAmqj\/06qllrqewYqpirfnu7HA3RT0KinSn2TTlwT0ljNevrIoQoEqAYNqXYA2rRqbBqPrFLHqL6qngbJlhSCNnlTljBBNV0JBwRSsJZnp5IHAb4f+W2AWbwIYtXgXxInAw1AczJraATJqoam13nk6VAPTuxSdrbNtnZUIYTD9M3igKUqX0jqMJGjSuqOTmESOZ7mQAbOIu1iTKBrSmVqpRKItLHg\/l0RCkmQa7JF7oUAnlWrJb3jgGQrMljODMHPBFlHCOHMF10BxGKNFiKTOCTbA2UDbtYGuw4FBo0biSlP\/1hZJvhbg7XF5uFlNugYyoKscbIZxnhI\/s3ZNr0Q+s2VXv\/WzsF+gFsprDypZIE4rDHgFftQFBH0wEIJFdtN0ugwbBlJmQKiISoOAh3Inkk5oIJqaiZmQk+sLOBYWBs2gWxto46tbNee7YgcK3k8lm4Bza+hkLT+HmS0LKbRGHLCHtjSBtImZz00gIat1UYlkHQ0GC6xJit2GgYCFSE25Pxtkd52H5QAXuCpHLP2LQdirdNqwgLq3hpgbogQqmC8GelO1gb5lgm+WiU0nwLKAtEWbcgaKoF8ouJR2L+mxGb43hfOVrgWAu4abZLN4i16rd3tV64yycft4Bq0buEYZs5OyGYopjUOYe3iGpSGyGjpbkVhwyxuUOK4R+BgQ+P0UdD\/0tWz4daYkEA4gC+Bze53BK4wuEixpe+5AaZX\/B+MJFnwEh5cSKYMoYNZJevbFe\/yLsklBpoAy++HLa11hW5u8RP9CoTpCsbwPV69rmKCZUTwAESg4e\/CghduORXUOVt0XWqHCJ+GOZfvdrAdSCb4QFsF5i1ZEi8vMsnhbVTyCfBr9K31ChrlOLDNDkyILFgf4VIqECXyXsQ8OIAv3Yd20JoID1zGNaFQ5UB2vBJGjo664pCHFNvPxdkL510Mv+slmZ790AzawZtZ4vBKIkksWGx+WIZG7m1rqqULymx+NIAyFckFC4ZB7dn0jhznnIJ+bEChVfFj2mRwFfKW3e1+\/1QwMYhx4WpYGePcGc8QO9lkreVUXRRe+n3xwv1td6TcUeZV11UuCHAc4YwwBxaWKSPe9qYnEF5Y9HUWSQwhvnLd2LHO+E7cRuGvjxGxblDyMFgykGEy3pFrHbjePgVaeCnQMqZQIn9dzZbpktztXTwQC31nCGjeApWUTqys5PZIIK8mdOkX7fWTTEYxXfkOI2syBxHA8BXiNFTffyBz\/V7VtklgM+\/fRPkb+GrH\/eJRdcywOzoCCzASPI\/e1y7J424hFDcQnx0lQYOkDaAROVvgFEBsNo8S3EZOSwTxM9lSEFuz2jDaPDuxzvxQqrVzO4zmJIexP7fwyQY0pqXRCf+7hUHr2RqRIxjkWzmJ8ETHcZCAZvsiICdfVTp2nPxML1CxDiE3MX6O9H6AjwbLly1Z5zOudD+1NFS+Wjv+mOoBHU2TBz\/\/AgvDZjh2G1iHVNx8jSL\/lELWD0iF2NZeEurCcZUWiQ8v8q6Z2lx7DdpEVEpj3gSjab96iFqsoeAx12k8XdRuUzu09BG67n89YAC6nYestS8c9ED1nk7D8DP7dQinGlFZGmP+tZCM5kkHlQ8\/AWJLMN5m7lU39gqHQoX0mc5q7v\/0sp1p3DcLHR5pYS5vmTHzh00Pz\/RWcSYz1\/9+wGx7MuTpHjwQ4HJPXZHcbWxn3dI4V2InL26XLlb\/e+o479Fp3KF0s4RwA7cN73HlZbcX5iwt5DPnqnVzOxoR\/vEkvTfjciZqm58XRq9Q\/YoBF7GOCNs9w27R9cF3dbRyja5fR3QtLzjWJlkqeg5cmOBD17VFrthccwWJ+Rb4ReJMeM40IDIpr1eB\/AzC8YyqMQCUdYPRKQIx1QwLPALj6DgzdkKM6yW0hdcAUOJCjZEqUi1S64i1mUY25ccm0IRVCxsHzoSRFxLNvFKRo5WzTkcIRTlJ8uuFi4gJ+qMfvnLY9Z+y5m1AOoDt7Zn8Oety+lgwhwho58JTv8UeqU74cOT6oGLSMaOfG6JZKeQ3vE2RuaZIC4lsVfP+qONp\/+U3dUN1pAVPJ\/15+wSPS5m3bjt24xAlu3UnN6jDeFPFprNVt\/lbAdQ5olsZla0Wux3BPaa1fg\/IRvjbcDAx+DaVqoeBqrvWrY8bi33rXAYQUODUrgfoLNMGdjKQ\/oA6+KKle5w6NdVEVdD4LfX6GYFb3iQ7IJ+3sFC5B1R3e9fBe5V6w24qOi+7ugdGOhcIupeNpEMvsIaWuNd6u79tvuv7mE8Lq\/tBhUP2E0BCQtv4VPfIne87L4yswhvEuxNID4R05WFZD0RYnssSrdd0w1MVu288Uzy8tmQ2dsBODnBV9tquxydwyg8quAfMIiADl6vwyvsHw898M4C8zUtEwqnnvMF0PM\/nBM7\/vELsvNDjgc8X\/UIEPdITBNEv\/RPUvNP3gtJHfT40PdX3y9WLbMtnvVFYPdeDANR\/\/St06IvSqNmfPdqnPaWUvdq3vdu\/fYsyANzPPd3X\/YeCjgNInt7vPd\/3vd\/\/PeAHvuAPPuEXvuEfPuInvuIvPuM3vuM\/PuRHvuRPPuVXvuVfPuZnvuZvPud3vud\/Pua3uNiPPumXvumfPurbfAQAADs=\" style=\"height=303;width=1024\" \/><\/p>&#13;\n&#13;\n<p>Inter-individual differences in absorption result in different times to reach maximum concentrations. The pharmacokinetic parameters of mefloquine are altered in malaria: patients with malaria have higher plasma concentrations and eliminate mefloquine more rapidly than healthy volunteers, possibly because of interruption of entero-hepatic cycling (24). The pharmacokinitic parameters of mefloquine are also highly stereospecific (3\u20135). Mefloquine is extensively distributed in the body; it crosses the blood\u2013brain-barrier and the placenta and is found in breast milk (21). It accumulates in erythrocytes, with an erythrocyte-to-plasma ratio of about 2:1 (24). Approximately 98.2% of mefloquine is bound to protein. In the liver, it is metabolized by CYP3A4, largely to an inactive metabolite (24). Mefloquine has a long elimination half-life (\u2264 3 weeks). Excretion occurs primarily via the bile and faeces as unchanged drug and metabolites, with a small proportion excreted unchanged in the urine.<\/p>&#13;\n&#13;\n<p>While mefloquine has no effect on the pharmacokinetics of dihydroartemisinin, concomitant administration of artesunate decreases the maximum concentration and increases the clearance rate and volume of distribution of mefloquine (6, 24). Delaying the dose of mefloquine to the second day of artesunate administration increases its estimated oral bioavailability substantially, probably as an indirect effect of rapid clinical improvement (10). Administration with food does not alter the kinetics of artesunate\u2013mefloquine (10, 17).<\/p>&#13;\n&#13;\n<p>The pharmacokinitic parameters of mefloquine are similar in children and adults (4, 23). Peak mefloquine concentrations in whole blood are lower during pregnancy than in non-pregnant individuals (8, 21). As the overall efficacy of the drug does not appear to be affected, however, dosage adjustment is not warranted for pregnant women.<\/p>&#13;\n&#13;\n<p><strong>Safety <\/strong><\/p>&#13;\n&#13;\n<p><em><strong>Adverse events <\/strong><\/em><\/p>&#13;\n&#13;\n<p>Although mefloquine is associated with higher incidences of central nervous system and gastrointestinal adverse effects than other ACTs, it is generally well tolerated when given in combination with artesunate for the treatment of uncomplicated malaria. Mefloquine has been associated with seizures, anxiety, irritability, dizziness, paranoia, suicidal ideation, depression, hallucinations and violence in patients treated for malaria and in people on long-term mefloquine prophylaxis (20, 24\u201331). Such neuropsychiatric adverse effects generally resolve after discontinuation of mefloquine. The estimated incidence of seizures, encephalopathy or psychotic reactions ranges from 1 in 10 000 healthy people receiving chemoprophylaxis, 1 in 1000 malaria patients in Asia, 1 in 200 malaria patients in Africa to 1 in 20 patients recovering from cerebral malaria. Mefloquine should therefore not be given to patients who have had cerebral malaria. Mefloquine prophylaxis should be avoided in travellers who require fine motor coordination or in whom sudden onset of dizziness or confusion may be hazardous, such as pilots and drivers. Travellers and their companions should be advised to monitor for adverse effects such as restlessness, anxiety, depression or confusion, and, if these occur, to discontinue mefloquine and seek medical attention.<\/p>&#13;\n&#13;\n<p>The most frequently reported adverse effect with treatment is vomiting or gastrointestinal disturbances, which tend to affect adherence and efficacy. Early vomiting was a predictor of treatment failure in patients given mefloquine for uncomplicated malaria (32). Mefloquine has been associated rarely with hepatitis, polyneuropathy, thrombocytopenia, pneumonia, skin rashes or irritation, sinus bradycardia and visual impairment (33\u201342). Adverse events appear to be associated with high concentrations of the (\u2013)-enantiomer rather than of the drug overall and to be more frequent in women than men (20, 43).<\/p>&#13;\n&#13;\n<p><em><strong>Contraindications <\/strong><\/em><\/p>&#13;\n&#13;\n<p>Mefloquine is contraindicated in patients with known hypersensitivity to mefloquine or related compounds (e.g. quinine and quinidine). It should not be prescribed for follow-up treatment after cerebral malaria or for prophylaxis in patients with active depression, a recent history of depression, generalized anxiety disorder, psychosis, schizophrenia or another major psychiatric disorder, or with epilepsy or a history of convulsions (24).<\/p>&#13;\n&#13;\n<p><em><strong>Caution <\/strong><\/em><\/p>&#13;\n&#13;\n<p>Given the lack of evidence on the safety of mefloquine in severe hepatic impairment, such patients should be monitored carefully because of a potential increase in the risk for adverse events. Clinical trials show no or only small, clinically insignificant alterations in the electrocardiogram after administration of mefloquine (39, 44); however, caution should be exrecised in administering mefloquine to patients with cardiac disease. The teratogenic and embryotoxic effects of mefloquine observed in experimental animals and the high rate of spontaneous abortions seen in one small study of mefloquine prophylaxis in pregnant women (45) have raised concern about the safety of mefloquine in pregnancy. Large clinical studies have not, however, revealed such adverse outcomes, allaying concern that mefloquine might be associated with stillbirth (46\u201348). Prophylactic doses of mefloquine in the second and third trimesters of pregnancy also appear to be effective and are not associated with adverse maternal or fetal outcomes (49, 50). However, gastrointestinal side-effects, including nausea and vomiting, are more common in pregnant women treated with mefloquine than those treated with SP (29).<\/p>&#13;\n&#13;\n<p><em><strong>Drug interactions<\/strong><\/em><\/p>&#13;\n&#13;\n<p>See Table A5.14.<\/p>&#13;\n&#13;\n<p><strong>Dose optimization <\/strong><\/p>&#13;\n&#13;\n<p>For the treatment of uncomplicated malaria in combination with artesunate, the recommended total dose of mefloquine is 25 mg\/kg bw, which gives a higher cure rate than the previously recommended dose of 15 mg\/kg bw. A pharmacokinetics model predicted that initial use of the lower (15-mg\/kg bw) dose of mefloquine resulted in a greater likelihood of selecting resistant mutants than de novo use of the higher (25-mg\/kg bw) dose (51). Giving mefloquine in two or three doses improves its tolerability and oral bioavailability. The fixed-dose combination of artesunate + mefloquine given daily for 3 days is preferred.<\/p>&#13;\n&#13;\n<p><strong>References<\/strong><\/p>&#13;\n&#13;\n<p>1. Dassonville-Klimpt A, Jonet A, Pillon M, Mulli\u00e9 C, Sonnet P. Mefloquine derivatives: synthesis, mechanisms of action, antimicrobial activities. In: Mendez-Vilas A, editor. Science against microbial pathogens: communicating current research and technological advances. Badajoz: Formatex Research Center; 2011:23\u201335.<\/p>&#13;\n&#13;\n<p>2. Hoppe HC, van Schalkwyk DA, Wiehart UI, Meredith SA, Egan J, Weber BW. Antimalarial quinolines and artemisinin inhibit endocytosis in <em>Plasmodium falciparum<\/em>. Antimicrob Agents Chemother 2004;48:2370\u20138.<\/p>&#13;\n&#13;\n<p>3. Gimenez F, Pennie RA, Koren G, Crevoisier C, Wainer IW, Farinotti R. Stereoselective pharmacokinetics of mefloquine in healthy Caucasians after multiple doses. J Pharm Sci 1994;83:824\u20137.<\/p>&#13;\n&#13;\n<p>4. Bourahla A, Martin C, Gimenez F, Singhasivanon V, Attanath P, Sabchearon A, et al. Stereoselective pharmacokinetics of mefloquine in young children. Eur J Clin Pharmacol 1996;50:241\u20134.<\/p>&#13;\n&#13;\n<p>5. Svensson US, Alin H, Karlsson MO, Bergqvist Y, Ashton M. Population pharmacokinetic and pharmacodynamic modelling of artemisinin and mefloquine enantiomers in patients with falciparum malaria. Eur J Clin Pharmacol 2002;58:339\u201351.<\/p>&#13;\n&#13;\n<p>6. Lefevre G, Bindschedler M, Ezzet F, Schaeffer N, Meyer I, Thomsen MS. Pharmacokinetic interaction trial between co-artemether and mefloquine. Eur J Pharm Sci 2000;10:141\u201351.<\/p>&#13;\n&#13;\n<p>7. Looareesuwan S, White NJ, Warrell DA, Forgo I, Dubach UG, Ranalder UB, et al. Studies of mefloquine bioavailability and kinetics using a stable isotope technique: a comparison of Thai patients with falciparum malaria and healthy Caucasian volunteers. Br J Clin Pharmacol 1987;24:37\u201342.<\/p>&#13;\n&#13;\n<p>8. Nosten F, Karbwang J, White NJ, Honeymoon, Na Bangchang K, Bunnag D, et al. Mefloquine antimalarial prophylaxis in pregnancy: dose finding and pharmacokinetic study. Br J Clin Pharmacol 1990;30:79\u201385.<\/p>&#13;\n&#13;\n<p>9. Crevoisier CA, Joseph I, Fischer M, Graf H. Influence of hemodialysis on plasma concentration\u2013time profiles of mefloquine in two patients with end- stage renal disease: a prophylactic drug monitoring study. Antimicrob Agents Chemother 1995;39:1892\u20135.<\/p>&#13;\n&#13;\n<p>10. Hellgren U, Berggren-Palme I, Bergqvist Y, Jerling M. Enantioselective pharmacokinetics of mefloquine during long-term intake of the prophylactic dose. Br J Clin Pharmacol 1997;44:119\u201324.<\/p>&#13;\n&#13;\n<p>11. Khaliq Y, Gallicano K, Tisdale C, Carignan G, Cooper C, McCarthy A. Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers. Br J Clin Pharmacol 2001;51:591\u2013600.<\/p>&#13;\n&#13;\n<p>12. Charles BG, Blomgren A, Nasveld PE, Kitchener SJ, Jensen A, Gregory RM, et al. Population pharmacokinetics of mefloquine in military personnel for prophylaxis against malaria infection during field deployment. Eur J Clin Pharmacol 2007;63:271\u20138.<\/p>&#13;\n&#13;\n<p>13. Bindschedler M, Lefevre G, Ezzet F, Schaeffer N, Meyer I, Thomsen MS. Cardiac effects of co-artemether (artemether\/lumefantrine) and mefloquine given alone or in combination to healthy volunteers. Eur J Clin Pharmacol 2000;56:375\u201381.<\/p>&#13;\n&#13;\n<p>14. Karbwang J, Bangchang KN, Supapojana A, Bunnag D, Harinasuta T. Pharmacokinetics of prophylactic mefloquine in Thai healthy volunteers. Southeast Asian J Trop Med Public Health 1991;22:68\u201371.<\/p>&#13;\n&#13;\n<p>15. Karbwang J, Na Bangchang K, Back DJ, Bunnag D. Effect of ampicillin on mefloquine pharmacokinetics in Thai males. Eur J Clin Pharmacol 1991;40:631\u20133.<\/p>&#13;\n&#13;\n<p>16. Karbwang J, Na Bangchang K, Back DJ, Bunnag D, Rooney W. Effect of tetracycline on mefloquine pharmacokinetics in Thai males. Eur J Clin Pharmacol 1992;43:567\u20139.<\/p>&#13;\n&#13;\n<p>17. Karbwang J, White NJ. Clinical pharmacokinetics of mefloquine. Clin Pharmacokin 1990;19:264\u201379.<\/p>&#13;\n&#13;\n<p>18. Kollaritsch H, Karbwang J, Wiedermann G, Mikolasek A, Na-Bangchang K, Wernsdorfer WH. Mefloquine concentration profiles during prophylactic dose regimens. Wien Klin Wochenschr 2000;112:441\u20137.<\/p>&#13;\n&#13;\n<p>19. Todd GD, Hopperus Buma AP, Green MD, Jaspers CA, Lobel HO. Comparison of whole blood and serum levels of mefloquine and its carboxylic acid metabolite. Am J Trop Med Hyg 1997;57:399\u2013402.<\/p>&#13;\n&#13;\n<p>20. Schwartz E, Potasman I, Rotenberg M, Almog S, Sadetzki S. Serious adverse events of mefloquine in relation to blood level and gender. Am J Trop Med Hyg 2001;65:189\u201392.<\/p>&#13;\n&#13;\n<p>21. Na Bangchang K, Davis TM, Looareesuwan S, White NJ, Bunnag D, Karbwang J. Mefloquine pharmacokinetics in pregnant women with acute falciparum malaria. Trans R Soc Trop Med Hyg 1994;88:321\u20133.<\/p>&#13;\n&#13;\n<p>22. Ashley EA, Stepniewska K, Lindegardh N, McGready R, Hutagalung R, Hae R, et al. Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria. Antimicrob Agents Chemother 2006;50:2281\u20135.<\/p>&#13;\n&#13;\n<p>23. Nosten F, ter Kuile F, Chongsuphajaisiddhi T, Na Bangchang K, Karbwang J, White NJ. Mefloquine pharmacokinetics and resistance in children with acute falciparum malaria. Br J Clin Pharmacol 1991;31:556\u20139. 24. Roche. Lariam product information.<\/p>&#13;\n&#13;\n<p>25. Tine RC, Faye B, Sylla K, Ndiaye JL, Ndiaye M, Sow D, et al. Efficacy and tolerability of a new formulation of artesunate\u2013mefloquine for the treatment of uncomplicated malaria in adult in Senegal: open randomized trial. Malar J 2012;11:416.<\/p>&#13;\n&#13;\n<p>26. van Riemsdijk MM, Sturkenboom MC, Pepplinkhuizen L, Stricker BH. Mefloquine increases the risk of serious psychiatric events during travel abroad: a nationwide case\u2013control study in the Netherlands. J Clin Psychiatry 2005;66:199\u2013204.<\/p>&#13;\n&#13;\n<p>27. Fuller SJ, Naraqi S, Gilessi G. Paranoid psychosis related to mefloquine antimalarial prophylaxis. Papua New Guinea Med J 2002;45:219\u201321.<\/p>&#13;\n&#13;\n<p>28. Bregani ER, Tien TV, Figini G. Mefloquine-induced grand mal seizure in tubercular meningitis. Panminerva Med 1998;40:345\u20136.<\/p>&#13;\n&#13;\n<p>29. Briand V, Bottero J, Noel H, Masse V, Cordel H, Guerra J, et al. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine\u2013 pyrimethamine with mefloquine. J Infect Dis 2009;200:991\u20131001.<\/p>&#13;\n&#13;\n<p>30. ter Kuile FO, Nosten F, Luxemburger C, Kyle D, Teja-Isavatharm P, Phaipun L, et al. Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients. Bull World Health Organ 1995;73:631\u201342.<\/p>&#13;\n&#13;\n<p>31. Gosling RD, Gesase S, Mosha JF, Carneiro I, Hashim R, Lemnge M, et al. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial. Lancet 2009;374:1521\u201332.<\/p>&#13;\n&#13;\n<p>32. ter Kuile FO, Luxemburger C, Nosten F, Thwai KL, Chongsuphajaisiddhi T, White NJ. Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg 1995;89:660\u20134.<\/p>&#13;\n&#13;\n<p>33. Chester AC, Sandroni P. Case report: peripheral polyneuropathy and mefloquine prophylaxis. Am J Trop Med Hyg 2011;85:1008\u20139.<\/p>&#13;\n&#13;\n<p>34. Fiaccadori E, Maggiore U, Rotelli C, Giacosa R, Parenti E, Cabassi A, et al. Thrombotic\u2013thrombocytopenic purpura following malaria prophylaxis with mefloquine. J Antimicrob Chemother 2006;57:160\u20131.<\/p>&#13;\n&#13;\n<p>35. Gotsman I, Azaz-Livshits T, Fridlender Z, Muszkat M, Ben-Chetrit E. Mefloquine-induced acute hepatitis. Pharmacotherapy 2000;20:1517\u20139.<\/p>&#13;\n&#13;\n<p>36. Grieco A, Vecchio FM, Natale L, Gasbarrini G. Acute fatty liver after malaria prophylaxis with mefloquine. Lancet 1999;353:295\u20136.<\/p>&#13;\n&#13;\n<p>37. Jha S, Kumar R, Kumar R. Mefloquine toxicity presenting with polyneuropathy\u2014a report of two cases in India. Trans R Soc Trop Med Hyg 2006;100:594\u20136.<\/p>&#13;\n&#13;\n<p>38. Katsenos S, Psathakis K, Nikolopoulou MI, Constantopoulos SH. Mefloquine- induced eosinophilic pneumonia. Pharmacotherapy 2007;27:1767\u201371.<\/p>&#13;\n&#13;\n<p>39. Laothavorn P, Karbwang J, Na Bangchang K, Bunnag D, Harinasuta T. Effect of mefloquine on electrocardiographic changes in uncomplicated falciparum malaria patients. Southeast Asian J Trop Med Public Health 1992;23:51\u20134.<\/p>&#13;\n&#13;\n<p>40. Pace JL. Psoriasis triggered by mefloquine. Skinmed 2010;8:301\u20132.<\/p>&#13;\n&#13;\n<p>41. Soentjens P, Delanote M, Van Gompel A. Mefloquine-induced pneumonitis. J Travel Med 2006;13:172\u20134.<\/p>&#13;\n&#13;\n<p>42. Udry E, Bailly F, Dusmet M, Schnyder P, Lemoine R, Fitting JW. Pulmonary toxicity with mefloquine. Eur Resp J 2001;18:890\u20132.<\/p>&#13;\n&#13;\n<p>43. Fletcher A, Di Shepherd R. Use of (+)-mefloquine for the treatment of malaria. Patent no. WO 1998039003 AI, 6 March 1998.<\/p>&#13;\n&#13;\n<p>44. Krudsood S, Looareesuwan S, Wilairatama P, Leowattana W, Tangpukdee N, Chalermrut K, et al. Effect of artesunate and mefloquine in combination on the Fridericia corrected QT intervals in <em>Plasmodium falciparum<\/em> infected adults from Thailand. Trop Med Int Health 2011;16:458\u201365.<\/p>&#13;\n&#13;\n<p>45. Smoak BL, Writer JV, Keep LW, Cowan J, Chantelois JL. The effects of inadvertent exposure of mefloquine chemoprophylaxis on pregnancy outcomes and infants of US Army servicewomen. J Infect Dis 1997;176:831\u20133.<\/p>&#13;\n&#13;\n<p>46. Phillips-Howard PA, Steffen R, Kerr L, Vanhauwere B, Schildknecht J, Fuchs E, et al. Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy. J Travel Med 1998;5:121\u20136.<\/p>&#13;\n&#13;\n<p>47. Vanhauwere B, Maradit H, Kerr L. Post-marketing surveillance of prophylactic mefloquine (Lariam) use in pregnancy. Am J Trop Med Hyg 1998;58:17\u201321.<\/p>&#13;\n&#13;\n<p>48. Steketee RW, Wirima JJ, Slutsker L, Khoromana CO, Heymann DL, Breman JG. Malaria treatment and prevention in pregnancy: indications for use and adverse events associated with use of chloroquine or mefloquine. Am J Trop Med Hyg 1996;55(Suppl 1):50\u20136.<\/p>&#13;\n&#13;\n<p>49. Nosten F, ter Kuile F, Maelankiri L, Chongsuphajaisiddhi T, Nopdonrattakoon L, Tangkitchot S, et al. Mefloquine prophylaxis prevents malaria during pregnancy: a double-blind, placebo-controlled study. J Infect Dis 1994;169:595\u2013603.<\/p>&#13;\n&#13;\n<p>50. Adam I, Ali DA, Alwaseila A, Kheir MM, Elbashir MI. Mefloquine in the treatment of falciparum malaria during pregnancy in eastern Sudan. Saudi Med J 2004;25:1400\u20132.<\/p>&#13;\n&#13;\n<p>51. Simpson JA, Watkins ER, Price RN, Aarons L, Kyle DE, White NJ. Mefloquine pharmacokinetic\u2013pharmacodynamic models: implications for dosing and resistance. Antimicrob Agents Chemother. 2000;44:3414\u201324.<\/p>&#13;\n","title":"A5.10 Mefloquine","nid":513,"vid":1472,"created":1573123669,"changed":1573197576,"field_content_type":{"tid":2,"name":"Content","class":"content"},"field_operational_":[{"field_image":"","field_link":"","field_title":null}],"field_references":null}